Mast Cell Proteases

Advances in Immunology

Volumn 95, Issue , 2007, Pages 167-255

  Pejler, Gunnar ^a   Åbrink, Magnus ^a   Ringvall, Maria ^a   Wernersson, Sara ^a  

^a SWEDISH UNIVERSITY OF AGRICULTURAL SCIENCES   (Sweden)

Author keywords

[No Author keywords available]

Indexed keywords

CARBOXYPEPTIDASE A; CHYMASE; CYTOKINE; HISTAMINE; SERGLYCIN PROTEOGLYCAN; SNAKE VENOM; TRYPTASE; UNCLASSIFIED DRUG;

ALLERGIC REACTION; ANGIOGENESIS; AUTOIMMUNE DISEASE; BACTERIUM; CELL INTERACTION; CELL STRUCTURE; DEFENSE MECHANISM; DEREGULATION; DNA CLEAVAGE; GENE TARGETING; GENETIC ORGANIZATION; GENETIC REGULATION; GENETIC TRANSCRIPTION; HOST CELL; HUMAN; IN VIVO STUDY; MAST CELL; MEDIATOR; MOLECULAR EVOLUTION; NONHUMAN; NUCLEOTIDE SEQUENCE; PARASITE; PRIORITY JOURNAL; PROTEIN EXPRESSION; REVIEW; STIMULUS; STRUCTURE ANALYSIS;

ANIMALS; EVOLUTION; FIBROSIS; HEART DISEASES; HUMANS; INFLAMMATION; MAST CELLS; MUSCLE, SMOOTH; PEPTIDE HYDROLASES; PROTEASE INHIBITORS; PROTEOGLYCANS;

EID: 34548504097     PISSN: 00652776     EISSN: None     Source Type: Book Series    
DOI: 10.1016/S0065-2776(07)95006-3     Document Type: Review

References (422)

1. Abe M., Kurosawa M., Ishikawa O., Miyachi Y., and Kido H. Mast cell tryptase stimulates both human dermal fibroblast proliferation and type I collagen production. Clin. Exp. Allergy 28 (1998) 1509-1517
2. Abe M., Kurosawa M., Ishikawa O., and Miyachi Y. Effect of mast cell-derived mediators and mast cell-related neutral proteases on human dermal fibroblast proliferation and type I collagen production. J. Allergy Clin. Immunol. 106 (2000) S78-S84
3. Abonia J.P., Friend D.S., Austen Jr. W.G., Moore Jr. F.D., Carroll M.C., Chan R., Afnan J., Humbles A., Gerard C., Knight P., Kanaoka Y., Yasuda S., et al. Mast cell protease 5 mediates ischemia-reperfusion injury of mouse skeletal muscle. J. Immunol. 174 (2005) 7285-7291
4. Åbrink M., Grujic M., and Pejler G. Serglycin is essential for maturation of mast cell secretory granule. J. Biol. Chem. 279 (2004) 40897-40905
5. Addington A.K., and Johnson D.A. Inactivation of human lung tryptase: Evidence for a re-activatable tetrameric intermediate and active monomers. Biochemistry 35 (1996) 13511-13518
6. Akers I.A., Parsons M., Hill M.R., Hollenberg M.D., Sanjar S., Laurent G.J., and McAnulty R.J. Mast cell tryptase stimulates human lung fibroblast proliferation via protease-activated receptor-2. Am. J. Physiol. Lung Cell. Mol. Physiol. 278 (2000) L193-L201
7. Algermissen B., Hermes B., Feldmann-Boeddeker I., Bauer F., and Henz B.M. Mast cell chymase and tryptase during tissue turnover: Analysis on in vitro mitogenesis of fibroblasts and keratinocytes and alterations in cutaneous scars. Exp. Dermatol. 8 (1999) 193-198
8. Alshurafa H.N., Stenton G.R., Wallace J.L., Hollenberg M.D., Befus A.D., and Vliagoftis H. A protease activated receptor-2 (PAR-2) activating peptide, tc-LIGRLO-NH2, induces protease release from mast cells: Role in TNF degradation. BMC Pharmacol. 4 (2004) 12
9. Alter S.C., Metcalfe D.D., Bradford T.R., and Schwartz L.B. Regulation of human mast cell tryptase. Effects of enzyme concentration, ionic strength and the structure and negative charge density of polysaccharides. Biochem. J. 248 (1987) 821-827
10. Badertscher K., Bronnimann M., Karlen S., Braathen L.R., and Yawalkar N. Mast cell chymase is increased in chronic atopic dermatitis but not in psoriasis. Arch. Dermatol. Res. 296 (2005) 503-506
11. Baglin T.P., Carrell R.W., Church F.C., Esmon C.T., and Huntington J.A. Crystal structures of native and thrombin-complexed heparin cofactor II reveal a multistep allosteric mechanism. Proc. Natl. Acad. Sci. USA 99 (2002) 11079-11084
12. Balzar S., Chu H.W., Strand M., and Wenzel S. Relationship of small airway chymase-positive mast cells and lung function in severe asthma. Am. J. Respir. Crit. Care Med. 171 (2005) 431-439
13. Banovac K., and De Forteza R. The effect of mast cell chymase on extracellular matrix: Studies in autoimmune thyroiditis and in cultured thyroid cells. Int. Arch. Allergy Immunol. 99 (1992) 141-149
14. Banovac K., Banovac F., Yang J., and Koren E. Interaction of osteoblasts with extracellular matrix: Effect of mast cell chymase. Proc. Soc. Exp. Biol. Med. 203 (1993) 221-235
15. Baram D., Vaday G.G., Salamon P., Drucker I., Hershkoviz R., and Mekori Y.A. Human mast cells release metalloproteinase-9 on contact with activated T cells: Juxtacrine regulation by TNF-alpha. J. Immunol. 167 (2001) 4008-4016
16. Barrios V.E., Middleton S.C., Kashem M.A., Havill A.M., Toombs C.F., and Wright C.D. Tryptase mediates hyperresponsiveness in isolated guinea pig bronchi. Life Sci. 63 (1998) 2295-2303
17. Bastos M., Maeji N.J., and Abeles R.H. Inhibitors of human heart chymase based on a peptide library. Proc. Natl. Acad. Sci. USA 92 (1995) 6738-6742
18. Berger P., Compton S.J., Molimard M., Walls A.F., N'Guyen C., Marthan R., and Tunon-De-Lara J.M. Mast cell tryptase as a mediator of hyperresponsiveness in human isolated bronchi. Clin. Exp. Allergy 29 (1999) 804-812
19. Bisacchi G.S., Slusarchyk W.A., Bolton S.A., Hartl K.S., Jacobs G., Mathur A., Meng W., Ogletree M.L., Pi Z., Sutton J.C., Treuner U., Zahler R., et al. Synthesis of potent and highly selective nonguanidine azetidinone inhibitors of human tryptase. Bioorg. Med. Chem. Lett. 14 (2004) 2227-2231
20. Blair R.J., Meng H., Marchese M.J., Ren S., Schwartz L.B., Tonnesen M.G., and Gruber B.L. Human mast cells stimulate vascular tube formation. Tryptase is a novel, potent angiogenic factor. J. Clin. Invest. 99 (1997) 2691-2700
21. Blank U., and Rivera J. The ins and outs of IgE-dependent mast-cell exocytosis. Trends Immunol. 25 (2004) 266-273
22. Braga T., Grujic M., Lukinius A., Hellman L., Abrink M., and Pejler G. Serglycin proteoglycan is required for secretory granule integrity in mucosal mast cells. Biochem. J. 403 (2007) 49-57
23. Briggaman R.A., Schechter N.M., Fraki J., and Lazarus G.S. Degradation of the epidermal-dermal junction by proteolytic enzymes from human skin and human polymorphonuclear leukocytes. J. Exp. Med. 160 (1984) 1027-1042
24. Brightling C.E., Bradding P., Symon F.A., Holgate S.T., Wardlaw A.J., and Pavord I.D. Mast-cell infiltration of airway smooth muscle in asthma. N. Engl. J. Med. 346 (2002) 1699-1705
25. Brown J.K., Tyler C.L., Jones C.A., Ruoss S.J., Hartmann T., and Caughey G.H. Tryptase, the dominant secretory granular protein in human mast cells, is a potent mitogen for cultured dog tracheal smooth muscle cells. Am. J. Respir. Cell Mol. Biol. 13 (1995) 227-236
26. Brown J.K., Jones C.A., Rooney L.A., Caughey G.H., and Hall I.P. Tryptase's potent mitogenic effects in human airway smooth muscle cells are via nonproteolytic actions. Am. J. Physiol. Lung Cell. Mol. Physiol. 282 (2002) L197-L206
27. Brown J.K., Knight P.A., Wright S.H., Thornton E.M., and Miller H.R. Constitutive secretion of the granule chymase mouse mast cell protease-1 and the chemokine, CCL2, by mucosal mast cell homologues. Clin. Exp. Allergy 33 (2003) 132-146
28. Brown J.K., Hollenberg M.D., and Jones C.A. Tryptase activates phosphatidylinositol 3-kinases proteolytically independent from proteinase activated receptor-2 in cultured dog airway smooth muscle cells. Am. J. Physiol. Lung Cell. Mol. Physiol. 290 (2005) L259-L269
29. Buckley M.G., Walters C., Wong W.M., Cawley M.I., Ren S., Schwartz L.B., and Walls A.F. Mast cell activation in arthritis: Detection of alpha- and beta-tryptase, histamine and eosinophil cationic protein in synovial fluid. Clin. Sci. (Lond.) 93 (1997) 363-370
30. Buckley M.G., Gallagher P.J., and Walls A.F. Mast cell subpopulations in the synovial tissue of patients with osteoarthritis: Selective increase in numbers of tryptase-positive, chymase-negative mast cells. J. Pathol. 186 (1998) 67-74
31. Buckley M.G., Variend S., and Walls A.F. Elevated serum concentrations of beta-tryptase, but not alpha-tryptase, in Sudden Infant Death Syndrome (SIDS). An investigation of anaphylactic mechanisms. Clin. Exp. Allergy 31 (2001) 1696-1704
32. Burgess L.E., Newhouse B.J., Ibrahim P., Rizzi J., Kashem M.A., Hartman A., Brandhuber B.J., Wright C.D., Thomson D.S., Vigers G.P., and Koch K. Potent selective nonpeptidic inhibitors of human lung tryptase. Proc. Natl. Acad. Sci. USA 96 (1999) 8348-8352
33. Caughey G. New developments in the genetics and activation of mast cell proteases. Mol. Immunol. 38 (2001) 1353-1357
34. Caughey G.H., Leidig F., Viro N.F., and Nadel J.A. Substance P and vasoactive intestinal peptide degradation by mast cell tryptase and chymase. J. Pharmacol. Exp. Ther. 244 (1988) 133-137
35. Caughey G.H., Raymond W.W., and Vanderslice P. Dog mast cell chymase: Molecular cloning and characterization. Biochemistry 29 (1990) 5166-5171
36. Caughey G.H., Zerweck E.H., and Vanderslice P. Structure, chromosomal assignment, and deduced amino acid sequence of a human gene for mast cell chymase. J. Biol. Chem. 266 (1991) 12956-12963
37. Caughey G.H., Raymond W.W., Bacci E., Lombardy R.J., and Tidwell R.R. Bis (5- amidino-2-benzimidazolyl)methane and related amidines are potent, reversible inhibitors of mast cell tryptases. J. Pharmacol. Exp. Ther. 264 (1993) 676-682
38. Caughey G.H., Schaumberg T.H., Zerweck E.H., Butterfield J.H., Hanson R.D., Silverman G.A., and Ley T.J. The human mast cell chymase gene (CMA1): Mapping to the cathepsin G/granzyme gene cluster and lineage-restricted expression. Genomics 15 (1993) 614-620
39. Caughey G.H., Raymond W.W., Blount J.L., Hau L.W., Pallaoro M., Wolters P.J., and Verghese G.M. Characterization of human gamma-tryptases, novel members of the chromosome 16p mast cell tryptase and prostasin gene families. J. Immunol. 164 (2000) 6566-6575
40. Caughey G.H., Raymond W.W., and Wolters P.J. Angiotensin II generation by mast cell alpha- and beta-chymases. Biochim. Biophys. Acta 1480 (2000) 245-257
41. Cavalcante M.C., de Andrade L.R., Du Bocage Santos-Pinto C., Straus A.H., Takahashi H.K., Allodi S., and Pavao M.S. Colocalization of heparin and histamine in the intracellular granules of test cells from the invertebrate Styela plicata (Chordata-Tunicata). J. Struct. Biol. 137 (2002) 313-321
42. Cenac N., Coelho A.M., Nguyen C., Compton S., Andrade-Gordon P., MacNaughton W.K., Wallace J.L., Hollenberg M.D., Bunnett N.W., Garcia-Villar R., Bueno L., Vergnolle N., et al. Induction of intestinal inflammation in mouse by activation of proteinase-activated receptor-2. Am. J. Pathol. 161 (2002) 1903-1915
43. Chandrasekharan U.M., Sanker S., Glynias M.J., Karnik S.S., and Husain A. Angiotensin II-forming activity in a reconstructed ancestral chymase. Science 271 (1996) 502-505
44. Chen L.Y., Li P., He Q., Jiang L.Q., Cui C.J., Xu L., and Liu L.S. Transgenic study of the function of chymase in heart remodeling. J. Hypertens. 20 (2002) 2047-2055
45. Chen R., Ning G., Zhao M.L., Fleming M.G., Diaz L.A., Werb Z., and Liu Z. Mast cells play a key role in neutrophil recruitment in experimental bullous pemphigoid. J. Clin. Invest. 108 (2001) 1151-1158
46. Chen Y., Shiota M., Ohuchi M., Towatari T., Tashiro J., Murakami M., Yano M., Yang B., and Kido H. Mast cell tryptase from pig lungs triggers infection by pneumotropic Sendai and influenza A viruses. Purification and characterization. Eur. J. Biochem. 267 (2000) 3189-3197
47. Chu W., Johnson D.A., and Musich P.R. Molecular cloning and characterization of mouse mast cell chymases. Biochim. Biophys. Acta 1121 (1992) 83-87
48. Clark J.M., Abraham W.M., Fishman C.E., Forteza R., Ahmed A., Cortes A., Warne R.L., Moore W.R., and Tanaka R.D. Tryptase inhibitors block allergen-induced airway and inflammatory responses in allergic sheep. Am. J. Respir. Crit. Care Med. 152 (1995) 2076-2083
49. Cole K.R., Kumar S., Trong H.L., Woodbury R.G., Walsh K.A., and Neurath H. Rat mast cell carboxypeptidase: Amino acid sequence and evidence of enzyme activity within mast cell granules. Biochemistry 30 (1991) 648-655
50. Compton S.J., Cairns J.A., Holgate S.T., and Walls A.F. The role of mast cell tryptase in regulating endothelial cell proliferation, cytokine release, and adhesion molecule expression: Tryptase induces expression of mRNA for IL-1 beta and IL-8 and stimulates the selective release of IL-8 from human umbilical vein endothelial cells. J. Immunol. 161 (1998) 1939-1946
51. Corvera C.U., Dery O., McConalogue K., Bohm S.K., Khitin L.M., Caughey G.H., Payan D.G., and Bunnett N.W. Mast cell tryptase regulates rat colonic myocytes through proteinase- activated receptor 2. J. Clin. Invest. 100 (1997) 1383-1393
52. Costanzo M.J., Yabut S.C., Almond Jr. H.R., Andrade-Gordon P., Corcoran T.W., De Garavilla L., Kauffman J.A., Abraham W.M., Recacha R., Chattopadhyay D., and Maryanoff B.E. Potent, small-molecule inhibitors of human mast cell tryptase. Antiasthmatic action of a dipeptide-based transition-state analogue containing a benzothiazole ketone. J. Med. Chem. 46 (2003) 3865-3876
53. Coussens L.M., Raymond W.W., Bergers G., Laig-Webster M., Behrendtsen O., Werb Z., Caughey G.H., and Hanahan D. Inflammatory mast cells up-regulate angiogenesis during squamous epithelial carcinogenesis. Genes Dev. 13 (1999) 1382-1397
54. Cregar L., Elrod K.C., Putnam D., and Moore W.R. Neutrophil myeloperoxidase is a potent and selective inhibitor of mast cell tryptase. Arch. Biochem. Biophys. 366 (1999) 125-130
55. de Garavilla L., Greco M.N., Sukumar N., Chen Z.W., Pineda A.O., Mathews F.S., Di Cera E., Giardino E.C., Wells G.I., Haertlein B.J., Kauffman J.A., Corcoran T.W., et al. A novel, potent dual inhibitor of the leukocyte proteases cathepsin G and chymase: Molecular mechanisms and anti-inflammatory activity in vivo. J. Biol. Chem. 280 (2005) 18001-18007
56. de Paulis A., Minopoli G., Dal Piaz F., Pucci P., Russo T., and Marone G. Novel autocrine and paracrine loops of the stem cell factor/chymase network. Int. Arch. Allergy Immunol. 118 (1999) 422-425
57. Dell'Italia L.J., and Husain A. Dissecting the role of chymase in angiotensin II formation and heart and blood vessel diseases. Curr. Opin. Cardiol. 17 (2002) 374-379
58. Dener J.M., Rice K.D., Newcomb W.S., Wang V.R., Young W.B., Gangloff A.R., Kuo E.Y., Cregar L., Putnam D., and Wong M. Dibasic inhibitors of human mast cell tryptase. Part 3: Identification of a series of potent and selective inhibitors containing the benzamidine functionality. Bioorg. Med. Chem. Lett. 11 (2001) 1629-1633
59. Dikov M.M., Springman E.B., Yeola S., and Serafin W.E. Processing of procarboxypeptidase A and other zymogens in murine mast cells. J. Biol. Chem. 269 (1994) 25897-25904
60. Dragonetti A., Baldassarre M., Castino R., Demoz M., Luini A., Buccione R., and Isidoro C. The lysosomal protease cathepsin D is efficiently sorted to and secreted from regulated secretory compartments in the rat basophilic/mast cell line RBL. J. Cell Sci. 113 Pt. 18 (2000) 3289-3298
61. Ebihara N., Funaki T., Murakami A., Takai S., and Miyazaki M. Mast cell chymase decreases the barrier function and inhibits the migration of corneal epithelial cells. Curr. Eye Res. 30 (2005) 1061-1069
62. Ebihara N., Takai S., Miyazaki M., and Murakami A. Mast cell chymase induces conjunctival epithelial cell apoptosis by a mechanism involving degradation of fibronectin. Curr. Eye Res. 30 (2005) 429-435
63. Echtenacher B., Mannel D.N., and Hultner L. Critical protective role of mast cells in a model of acute septic peritonitis. Nature 381 (1996) 75-77
64. Eklund K.K., Ghildyal N., Austen K.F., and Stevens R.L. Induction by IL-9 and suppression by IL-3 and IL-4 of the levels of chromosome 14-derived transcripts that encode late-expressed mouse mast cell proteases. J. Immunol. 151 (1993) 4266-4273
65. Eklund K.K., Humphries D.E., Xia Z., Ghildyal N., Friend D.S., Gross V., and Stevens R.L. Glucocorticoids inhibit the cytokine-induced proliferation of mast cells, the high affinity IgE receptor-mediated expression of TNF-alpha, and the IL-10-induced expression of chymases. J. Immunol. 158 (1997) 4373-4380
66. Elrod K.C., Moore W.R., Abraham W.M., and Tanaka R.D. Lactoferrin, a potent tryptase inhibitor, abolishes late-phase airway responses in allergic sheep. Am. J. Respir. Crit. Care Med. 156 (1997) 375-381
67. Enerback L., Kolset S.O., Kusche M., Hjerpe A., and Lindahl U. Glycosaminoglycans in rat mucosal mast cells. Biochem. J. 227 (1985) 661-668
68. Erbaa F., Fiorucci L., Pascarella S., Menegatti E., Ascenzi P., and Ascoli F. Selective inhibition of human mast cell tryptase by gabexate mesylate, an antiproteinase drug. Biochem. Pharmacol. 61 (2001) 271-276
69. Everitt M.T., and Neurath H. Rat peritoneal mast cell carboxypeptidase: Localization, purification, and enzymatic properties. FEBS Lett. 110 (1980) 292-296
70. Fajardo I., and Pejler G. Formation of active monomers from tetrameric human beta-tryptase. Biochem. J. 369 (2003) 603-610
71. Fajardo I., and Pejler G. Human mast cell beta-tryptase is a gelatinase. J. Immunol. 171 (2003) 1493-1499
72. Fang K.C., Raymond W.W., Lazarus S.C., and Caughey G.H. Dog mastocytoma cells secrete a 92-kD gelatinase activated extracellularly by mast cell chymase. J. Clin. Invest. 97 (1996) 1589-1596
73. Fang K.C., Raymond W.W., Blount J.L., and Caughey G.H. Dog mast cell alpha-chymase activates progelatinase B by cleaving the Phe88-Gln89 and Phe91-Glu92 bonds of the catalytic domain. J. Biol. Chem. 272 (1997) 25628-25635
74. Fath M.A., Wu X., Hileman R.E., Linhardt R.J., Kashem M.A., Nelson R.M., Wright C.D., and Abraham W.M. Interaction of secretory leukocyte protease inhibitor with heparin inhibits proteases involved in asthma. J. Biol. Chem. 273 (1998) 13563-13569
75. Faurschou M., and Borregaard N. Neutrophil granules and secretory vesicles in inflammation. Microbes Infect. 5 (2003) 1317-1327
76. Feyerabend T.B., Hausser H., Tietz A., Blum C., Hellman L., Straus A.H., Takahashi H.K., Morgan E.S., Dvorak A.M., Fehling H.J., and Rodewald H.R. Loss of histochemical identity in mast cells lacking carboxypeptidase A. Mol. Cell. Biol. 25 (2005) 6199-6210
77. Forsberg E., and Kjellen L. Heparan sulfate: Lessons from knockout mice. J. Clin. Invest. 108 (2001) 175-180
78. Forsberg E., Pejler G., Ringvall M., Lunderius C., Tomasini-Johansson B., Kusche-Gullberg M., Eriksson I., Ledin J., Hellman L., and Kjellen L. Abnormal mast cells in mice deficient in a heparin-synthesizing enzyme [see comments]. Nature 400 (1999) 773-776
79. Franconi G.M., Graf P.D., Lazarus S.C., Nadel J.A., and Caughey G.H. Mast cell tryptase and chymase reverse airway smooth muscle relaxation induced by vasoactive intestinal peptide in the ferret. J. Pharmacol. Exp. Ther. 248 (1989) 947-951
80. Frank B.T., Rossall J.C., Caughey G.H., and Fang K.C. Mast cell tissue inhibitor of metalloproteinase-1 is cleaved and inactivated extracellularly by alpha-chymase. J. Immunol. 166 (2001) 2783-2792
81. Frungieri M.B., Weidinger S., Meineke V., Kohn F.M., and Mayerhofer A. Proliferative action of mast-cell tryptase is mediated by PAR2, COX2, prostaglandins, and PPARgamma: Possible relevance to human fibrotic disorders. Proc. Natl. Acad. Sci. USA 99 (2002) 15072-15077
82. Fukami H., Imajo S., Ito A., Kakutani S., Shibata H., Sumida M., Tanaka T., Niwata S., Saitoh M., Kiso Y., Miyazaki M., Okunishi H., et al. Substituted 3-phenylsulfonylquinazoline-2,4-dione derivatives as novel nonpeptide inhibitors of human heart chymase. Drug Des. Discov. 17 (2000) 69-84
83. Fukuda M., Ohkubo T., Katsuya T., Hozawa A., Asai T., Matsubara M., Kitaoka H., Tsuji I., Araki T., Satoh H., Higaki J., Hisamichi S., et al. Association of a mast cell chymase gene variant with HDL cholesterol, but not with blood pressure in the Ohasama study. Hypertens. Res. 25 (2002) 179-184
84. Fukuoka Y., and Schwartz L.B. Human beta-tryptase: Detection and characterization of the active monomer and prevention of tetramer reconstitution by protease inhibitors. Biochemistry 43 (2004) 10757-10764
85. Funaba M., Ikeda T., Murakami M., Ogawa K., Tsuchida K., Sugino H., and Abe M. Transcriptional activation of mouse mast cell Protease-7 by activin and transforming growth factor-beta is inhibited by microphthalmia-associated transcription factor. J. Biol. Chem. 278 (2003) 52032-52041
86. Galli S.J., Kalesnikoff J., Grimbaldeston M.A., Piliponsky A.M., Williams C.M., and Tsai M. Mast cells as "tunable" effector and immunoregulatory cells: Recent advances. Annu. Rev. Immunol. 23 (2005) 749-786
87. Galli S.J., Nakae S., and Tsai M. Mast cells in the development of adaptive immune responses. Nat. Immunol. 6 (2005) 135-142
88. Gallwitz M., and Hellman L. Rapid lineage-specific diversification of the mast cell chymase locus during mammalian evolution. Immunogenetics 58 (2006) 641-654
89. Gallwitz M., Reimer J.M., and Hellman L. Expansion of the mast cell chymase locus over the past 200 million years of mammalian evolution. Immunogenetics 58 (2006) 655-669
90. Gambacurta A., Fiorucci L., Basili P., Erba F., Amoresano A., and Ascoli F. Bovine tryptases. Eur. J. Biochem. 270 (2003) 507-517
91. Ge Y., Jippo T., Lee Y.M., Adachi S., and Kitamura Y. Independent influence of strain difference and mi transcription factor on the expression of mouse mast cell chymases. Am. J. Pathol. 158 (2001) 281-292
92. Gervasoni Jr. J.E., Conrad D.H., Hugli T.E., Schwartz L.B., and Ruddy S. Degradation of human anaphylatoxin C3a by rat peritoneal mast cells: A role for the secretory granule enzyme chymase and heparin proteoglycan. J. Immunol. 136 (1986) 285-292
93. Ghildyal N., Friend D.S., Stevens R.L., Austen K.F., Huang C., Penrose J.F., Sali A., and Gurish M.F. Fate of two mast cell tryptases in V3 mastocytosis and normal BALB/c mice undergoing passive systemic anaphylaxis: Prolonged retention of exocytosed mMCP-6 in connective tissues, and rapid accumulation of enzymatically active mMCP-7 in the blood. J. Exp. Med. 184 (1996) 1061-1073
94. Goldstein S.M., Kaempfer C.E., Kealey J.T., and Wintroub B.U. Human mast cell carboxypeptidase. Purification and characterization. J. Clin. Invest. 83 (1989) 1630-1636
95. Goldstein S.M., Leong J., and Bunnett N.W. Human mast cell proteases hydrolyze neurotensin, kinetensin and Leu5-enkephalin. Peptides 12 (1991) 995-1000
96. Goldstein S.M., Leong J., Schwartz L.B., and Cooke D. Protease composition of exocytosed human skin mast cell protease- proteoglycan complexes. Tryptase resides in a complex distinct from chymase and carboxypeptidase. J. Immunol. 148 (1992) 2475-2482
97. Gordon J.R., Burd P.R., and Galli S.J. Mast cells as a source of multifunctional cytokines. Immunol. Today 11 (1990) 458-464
98. Gruber B.L., Marchese M.J., Suzuki K., Schwartz L.B., Okada Y., Nagase H., and Ramamurthy N.S. Synovial procollagenase activation by human mast cell tryptase dependence upon matrix metalloproteinase 3 activation. J. Clin. Invest. 84 (1989) 1657-1662
99. Gruber B.L., Kew R.R., Jelaska A., Marchese M.J., Garlick J., Ren S., Schwartz L.B., and Korn J.H. Human mast cells activate fibroblasts: Tryptase is a fibrogenic factor stimulating collagen messenger ribonucleic acid synthesis and fibroblast chemotaxis. J. Immunol. 158 (1997) 2310-2317
100. Gumprecht J., Zychma M., Grzeszczak W., Lacka B., Burak W., Mosur M., Kaczmarski J., Otulski I., Stoklosa T., and Czank P. Angiotensin I-converting enzyme and chymase gene polymorphisms-relationship to left ventricular mass in type 2 diabetes patients. Med. Sci. Monit. 8 (2002) CR603-CR606
101. Guo C., Ju H., Leung D., Massaeli H., Shi M., and Rabinovitch M. A novel vascular smooth muscle chymase is upregulated in hypertensive rats. J. Clin. Invest. 107 (2001) 703-715
102. Gurish M.F., and Boyce J.A. Mast cell growth, differentiation, and death. Clin. Rev. Allergy Immunol. 22 (2002) 107-118
103. Gurish M.F., Ghildyal N., McNeil H.P., Austen K.F., Gillis S., and Stevens R.L. Differential expression of secretory granule proteases in mouse mast cells exposed to interleukin 3 and c-kit ligand. J. Exp. Med. 175 (1992) 1003-1012
104. Guyot N., Zani M.L., Berger P., Dallet-Choisy S., and Moreau T. Proteolytic susceptibility of the serine protease inhibitor trappin-2 (pre-elafin): Evidence for tryptase-mediated generation of elafin. Biol. Chem. 386 (2005) 391-399
105. Ha T.Y., Reed N.D., and Crowle P.K. Delayed expulsion of adult Trichinella spiralis by mast cell-deficient W/Wv mice. Infect. Immun. 41 (1983) 445-447
106. Hallgren J., and Pejler G. Biology of mast cell tryptase. An inflammatory mediator. FEBS J. 273 (2006) 1871-1895
107. Hallgren J., Karlson U., Poorafshar M., Hellman L., and Pejler G. Mechanism for activation of mouse mast cell tryptase: Dependence on heparin and acidic pH for formation of active tetramers of mouse mast cell protease 6. Biochemistry 39 (2000) 13068-13077
108. Hallgren J., Estrada S., Karlson U., Alving K., and Pejler G. Heparin antagonists are potent inhibitors of mast cell tryptase. Biochemistry 40 (2001) 7342-7349
109. Hallgren J., Spillmann D., and Pejler G. Structural requirements and mechanism for heparin-induced activation of a recombinant mouse mast cell tryptase, mouse mast cell protease-6: Formation of active tryptase monomers in the presence of low molecular weight heparin. J. Biol. Chem. 276 (2001) 42774-42781
110. Hallgren J., Backstrom S., Estrada S., Thuveson M., and Pejler G. Histidines are critical for heparin-dependent activation of mast cell tryptase. J. Immunol. 173 (2004) 1868-1875
111. Hallgren J., Lindahl S., and Pejler G. Structural requirements and mechanism for heparin-dependent activation and tetramerization of human betaI- and betaII-tryptase. J. Mol. Biol. 345 (2005) 129-139
112. Hamada H., Terai M., Kimura H., Hirano K., Oana S., and Niimi H. Increased expression of mast cell chymase in the lungs of patients with congenital heart disease associated with early pulmonary vascular disease. Am. J. Respir. Crit. Care Med. 160 (1999) 1303-1308
113. Hara M., Ono K., Hwang M.W., Iwasaki A., Okada M., Nakatani K., Sasayama S., and Matsumori A. Evidence for a role of mast cells in the evolution to congestive heart failure. J. Exp. Med. 195 (2002) 375-381
114. Harris J.L., Niles A., Burdick K., Maffitt M., Backes B.J., Ellman J.A., Kuntz I., Haak-Frendscho M., and Craik C.S. Definition of the extended substrate specificity determinants for beta-tryptases I and II. J. Biol. Chem. 276 (2001) 34941-34947
115. Hartmann T., Ruoss S.J., Raymond W.W., Seuwen K., and Caughey G.H. Human tryptase as a potent, cell-specific mitogen: Role of signaling pathways in synergistic responses. Am. J. Physiol. 262 (1992) L528-L534
116. Harvima I.T., Naukkarinen A., Harvima R.J., Aalto M.L., Neittaanmaki H., and Horsmanheimo M. Quantitative enzyme-histochemical analysis of tryptase- and chymase-containing mast cells in psoriatic skin. Arch. Dermatol. Res. 282 (1990) 428-433
117. He S., and Walls A.F. Human mast cell tryptase: A stimulus of microvascular leakage and mast cell activation. Eur. J. Pharmacol. 328 (1997) 89-97
118. He S., and Walls A.F. Human mast cell chymase induces the accumulation of neutrophils, eosinophils and other inflammatory cells in vivo. Br. J. Pharmacol. 125 (1998) 1491-1500
119. He S., and Walls A.F. The induction of a prolonged increase in microvascular permeability by human mast cell chymase. Eur. J. Pharmacol. 352 (1998) 91-98
120. He S., Peng Q., and Walls A.F. Potent induction of a neutrophil and eosinophil-rich infiltrate in vivo by human mast cell tryptase: Selective enhancement of eosinophil recruitment by histamine. J. Immunol. 159 (1997) 6216-6225
121. He S., Gaca M.D., and Walls A.F. A role for tryptase in the activation of human mast cells: Modulation of histamine release by tryptase and inhibitors of tryptase. J. Pharmacol. Exp. Ther. 286 (1998) 289-297
122. Henningsson F., Ledin J., Lunderius C., Wilen M., Hellman L., and Pejler G. Altered storage of proteases in mast cells from mice lacking heparin: A possible role for heparin in carboxypeptidase A processing. Biol. Chem. 383 (2002) 793-801
123. Henningsson F., Wolters P., Chapman H.A., Caughey G.H., and Pejler G. Mast cell cathepsins C and S control levels of carboxypeptidase A and the chymase, mouse mast cell protease 5. Biol. Chem. 384 (2003) 1527-1531
124. Henningsson F., Yamamoto K., Saftig P., Reinheckel T., Peters C., Knight S.D., and Pejler G. A role for cathepsin E in the processing of mast-cell carboxypeptidase A. J. Cell Sci. 118 (2005) 2035-2042
125. Henningsson F., Hergeth S., Cortelius R., Åbrink M., and Pejler G. A role for serglycin proteoglycan in granular retention and processing of mast cell secretory granule components. FEBS J. 273 (2006) 4901-4912
126. Hoshino F., Urata H., Inoue Y., Saito Y., Yahiro E., Ideishi M., Arakawa K., and Saku K. Chymase inhibitor improves survival in hamsters with myocardial infarction. J. Cardiovasc. Pharmacol. 41 Suppl. 1 (2003) S11-S18
127. Huang C., Wong G.W., Ghildyal N., Gurish M.F., Sali A., Matsumoto R., Qiu W.T., and Stevens R.L. The tryptase, mouse mast cell protease 7, exhibits anticoagulant activity in vivo and in vitro due to its ability to degrade fibrinogen in the presence of the diverse array of protease inhibitors in plasma. J. Biol. Chem. 272 (1997) 31885-31893
128. Huang C., Friend D.S., Qiu W.T., Wong G.W., Morales G., Hunt J., and Stevens R.L. Induction of a selective and persistent extravasation of neutrophils into the peritoneal cavity by tryptase mouse mast cell protease 6. J. Immunol. 160 (1998) 1910-1919
129. Huang C., De Sanctis G.T., O'Brien P.J., Mizgerd J.P., Friend D.S., Drazen J.M., Brass L.F., and Stevens R.L. Evaluation of the substrate specificity of human mast cell tryptase beta I and demonstration of its importance in bacterial infections of the lung. J. Biol. Chem. 276 (2001) 26276-26284
130. Huang R., and Hellman L. Cloning and structural analysis of a novel mouse mast cell specific serine protease, the MMCP-6: A connective tissue mast cell specific tryptase. In: de Wek A.L. (Ed). "Proceedings of XIV International Congress of Allergology and Clinical Immunology" (1991), Hoerefe & Huber, Kyoto, Japan 122
131. Huang R., and Hellman L. Genes for mast-cell serine protease and their molecular evolution. Immunogenetics 40 (1994) 397-414
132. Huang R.Y., Blom T., and Hellman L. Cloning and structural analysis of MMCP-1, MMCP-4 and MMCP-5, three mouse mast cell-specific serine proteases. Eur. J. Immunol. 21 (1991) 1611-1621
133. Huang R., Abrink M., Gobl A.E., Nilsson G., Aveskogh M., Larsson L.G., Nilsson K., and Hellman L. Expression of a mast cell tryptase in the human monocytic cell lines U-937 and Mono Mac 6. Scand. J. Immunol. 38 (1993) 359-367
134. Hultsch T., Ennis M., and Heidtmann H.H. The role of chymase in ionophore-induced histamine release from human pulmonary mast cells. Adv. Exp. Med. Biol. 240 (1988) 133-136
135. Humphries D.E., Wong G.W., Friend D.S., Gurish M.F., Qiu W.T., Huang C., Sharpe A.H., and Stevens R.L. Heparin is essential for the storage of specific granule proteases in mast cells [see comments]. Nature 400 (1999) 769-772
136. Hunt J.E., Friend D.S., Gurish M.F., Feyfant E., Sali A., Huang C., Ghildyal N., Stechschulte S., Austen K.F., and Stevens R.L. Mouse mast cell protease 9, a novel member of the chromosome 14 family of serine proteases that is selectively expressed in uterine mast cells. J. Biol. Chem. 272 (1997) 29158-29166
137. Huttunen M., and Harvima I.T. Mast cell tryptase and chymase in chronic leg ulcers: Chymase is potentially destructive to epithelium and is controlled by proteinase inhibitors. Br. J. Dermatol. 152 (2005) 1149-1160
138. Imada T., Komorita N., Kobayashi F., Naito K., Yoshikawa T., Miyazaki M., Nakamura N., and Kondo T. Therapeutic potential of a specific chymase inhibitor in atopic dermatitis. Jpn. J. Pharmacol. 90 (2002) 214-217
139. Imamura T., Dubin A., Moore W., Tanaka R., and Travis J. Induction of vascular permeability enhancement by human tryptase: Dependence on activation of prekallikrein and direct release of bradykinin from kininogens. Lab. Invest. 74 (1996) 861-870
140. Itoh H., Murakumo Y., Tomita M., Ide H., Kobayashi T., Maruyama H., Horii Y., and Nawa Y. Cloning of the cDNAs for mast-cell chymases from the jejunum of Mongolian gerbils, Meriones unguiculatus, and their sequence similarities with chymases expressed in the connective-tissue mast cells of mice and rats. Biochem. J. 314 (1996) 923-929
141. Iwanaga T., McEuen A., Walls A.F., Clough J.B., Keith T.P., Rorke S., Barton S.J., Holgate S.T., and Holloway J.W. Polymorphism of the mast cell chymase gene (CMA1) promoter region: Lack of association with asthma but association with serum total immunoglobulin E levels in adult atopic dermatitis. Clin. Exp. Allergy 34 (2004) 1037-1042
142. Jarjour N.N., Calhoun W.J., Schwartz L.B., and Busse W.W. Elevated bronchoalveolar lavage fluid histamine levels in allergic asthmatics are associated with increased airway obstruction. Am. Rev. Respir. Dis. 144 (1991) 83-87
143. Jarvikallio A., Naukkarinen A., Harvima I.T., Aalto M.L., and Horsmanheimo M. Quantitative analysis of tryptase- and chymase-containing mast cells in atopic dermatitis and nummular eczema. Br. J. Dermatol. 136 (1997) 871-877
144. Jin D., Takai S., Yamada M., Sakaguchi M., Kamoshita K., Ishida K., Sukenaga Y., and Miyazaki M. Impact of chymase inhibitor on cardiac function and survival after myocardial infarction. Cardiovasc. Res. 60 (2003) 413-420
145. Jin D., Ueda H., Takai S., Okamoto Y., Muramatsu M., Sakaguchi M., Shibahara N., Katsuoka Y., and Miyazaki M. Effect of chymase inhibition on the arteriovenous fistula stenosis in dogs. J. Am. Soc. Nephrol. 16 (2005) 1024-1034
146. Jippo T., Lee Y.M., Katsu Y., Tsujino K., Morii E., Kim D.K., Kim H.M., and Kitamura Y. Deficient transcription of mouse mast cell protease 4 gene in mutant mice of mi/mi genotype. Blood 93 (1999) 1942-1950
147. Jogie-Brahim S., Min H.K., Fukuoka Y., Xia H.Z., and Schwartz L.B. Expression of alpha-tryptase and beta-tryptase by human basophils. J. Allergy Clin. Immunol. 113 (2004) 1086-1092
148. Johnson L.A., Moon K.E., and Eisenberg M. Purification to homogeneity of the human skin chymotryptic proteinase "chymase.". Anal. Biochem. 155 (1986) 358-364
149. Jones S.E., Gilbert R.E., and Kelly D.J. Tranilast reduces mesenteric vascular collagen deposition and chymase-positive mast cells in experimental diabetes. J. Diabetes Complications 18 (2004) 309-315
150. Ju H., Gros R., You X., Tsang S., Husain M., and Rabinovitch M. Conditional and targeted overexpression of vascular chymase causes hypertension in transgenic mice. Proc. Natl. Acad. Sci. USA 98 (2001) 7469-7474
151. Kajita T., and Hugli T.E. Evidence for in vivo degradation of C3a anaphylatoxin by mast cell chymase. I. Nonspecific activation of rat peritoneal mast cells by C3ades Arg. Am. J. Pathol. 138 (1991) 1359-1369
152. Kakizoe E., Shiota N., Tanabe Y., Shimoura K., Kobayashi Y., and Okunishi H. Isoform-selective upregulation of mast cell chymase in the development of skin fibrosis in scleroderma model mice. J. Invest. Dermatol. 116 (2001) 118-123
153. Kaminska R., Helisalmi P., Harvima R.J., Naukkarinen A., Horsmanheimo M., and Harvima I.T. Focal dermal-epidermal separation and fibronectin cleavage in basement membrane by human mast cell tryptase. J. Invest. Dermatol. 113 (1999) 567-573
154. Karlson U., Pejler G., Froman G., and Hellman L. Rat mast cell protease 4 is a beta-chymase with unusually stringent substrate recognition profile. J. Biol. Chem. 277 (2002) 18579-18585
155. Karlson U., Pejler G., Tomasini-Johansson B., and Hellman L. Extended substrate specificity of rat mast cell protease 5, a rodent alpha-chymase with elastase-like primary specificity. J. Biol. Chem. 278 (2003) 39625-39631
156. Katz B.A., Clark J.M., Finer-Moore J.S., Jenkins T.E., Johnson C.R., Ross M.J., Luong C., Moore W.R., and Stroud R.M. Design of potent selective zinc-mediated serine protease inhibitors. Nature 391 (1998) 608-612
157. Kelso E.B., Lockhart J.C., Hembrough T., Dunning L., Plevin R., Hollenberg M.D., Sommerhoff C.P., McLean J.S., and Ferrell W.R. Therapeutic Promise of Par2 Antagonism in Joint Inflammation. J. Pharmacol. Exp. Ther. 316 3 (2005) 1017-1024
158. Kido H., Fukusen N., and Katunuma N. Antibody and inhibitor of chymase inhibit histamine release in immunoglobulin E-activated mast cells. Biochem. Int. 10 (1985) 863-871
159. Kido H., Nakano A., Okishima N., Wakabayashi H., Kishi F., Nakaya Y., Yoshizumi M., and Tamaki T. Human chymase, an enzyme forming novel bioactive 31-amino acid length endothelins. Biol. Chem. 379 (1998) 885-891
160. Kielty C.M., Lees M., Shuttleworth C.A., and Woolley D. Catabolism of intact type VI collagen microfibrils: Susceptibility to degradation by serine proteinases. Biochem. Biophys. Res. Commun. 191 (1993) 1230-1236
161. Kim D.K., and Lee Y.M. Requirement of c-jun transcription factor on the mouse mast cell protease-6 expression in the mast cells. Arch. Biochem. Biophys. 431 (2004) 71-78
162. Kjellén L., Pettersson I., Lillhager P., Steen M.L., Pettersson U., Lehtonen P., Karlsson T., Ruoslahti E., and Hellman L. Primary structure of a mouse mastocytoma proteoglycan core protein. Biochem. J. 263 (1989) 105-113
163. Knight P.A., Wright S.H., Lawrence C.E., Paterson Y.Y., and Miller H.R. Delayed expulsion of the nematode Trichinella spiralis in mice lacking the mucosal mast cell-specific granule chymase, mouse mast cell protease-1. J. Exp. Med. 192 (2000) 1849-1856
164. Kofford M.W., Schwartz L.B., Schechter N.M., Yager D.R., Diegelmann R.F., and Graham M.F. Cleavage of type I procollagen by human mast cell chymase initiates collagen fibril formation and generates a unique carboxyl-terminal propeptide. J. Biol. Chem. 272 (1997) 7127-7131
165. Koka V., Wang W., Huang X.R., Kim-Mitsuyama S., Truong L.D., and Lan H.Y. Advanced glycation end products activate a chymase-dependent angiotensin II-generating pathway in diabetic complications. Circulation 113 (2006) 1353-1360
166. Kokkonen J.O., Vartiainen M., and Kovanen P.T. Low density lipoprotein degradation by secretory granules of rat mast cells. Sequential degradation of apolipoprotein B by granule chymase and carboxypeptidase A. J. Biol. Chem. 261 (1986) 16067-16072
167. Kondo K., Muramatsu M., Okamoto Y., Jin D., Takai S., Tanigawa N., and Miyazaki M. Expression of chymase-positive cells in gastric cancer and its correlation with the angiogenesis. J. Surg. Oncol. 93 (2006) 36-42 ; discussion 42-33
168. Kondo S., Kagami S., Kido H., Strutz F., Muller G.A., and Kuroda Y. Role of mast cell tryptase in renal interstitial fibrosis. J. Am. Soc. Nephrol. 12 (2001) 1668-1676
169. Krishna M.T., Chauhan A., Little L., Sampson K., Hawksworth R., Mant T., Djukanovic R., Lee T., and Holgate S. Inhibition of mast cell tryptase by inhaled APC 366 attenuates allergen- induced late-phase airway obstruction in asthma. J. Allergy Clin. Immunol. 107 (2001) 1039-1045
170. Kunori Y., Koizumi M., Masegi T., Kasai H., Kawabata H., Yamazaki Y., and Fukamizu A. Rodent alpha-chymases are elastase-like proteases. Eur. J. Biochem. 269 (2002) 5921-5930
171. Kusche-Gullberg M., Eriksson I., Pikas D.S., and Kjellén L. Identification and expression in mouse of two heparan sulfate glucosaminyl N-deacetylase/N-sulfotransferase genes. J. Biol. Chem. 273 (1998) 11902-11907
172. Lane D.A., Pejler G., Flynn A.M., Thompson E.A., and Lindahl U. Neutralization of heparin-related saccharides by histidine-rich glycoprotein and platelet factor 4 [published erratum appears in J. Biol. Chem. (1986 Oct 5) 261(28), 13387]. J. Biol. Chem. 261 (1986) 3980-3986
173. Lazaar A.L., Plotnick M.I., Kucich U., Crichton I., Lotfi S., Das S.K., Kane S., Rosenbloom J., Panettieri Jr. R.A., Schechter N.M., and Pure E. Mast cell chymase modifies cell-matrix interactions and inhibits mitogen-induced proliferation of human airway smooth muscle cells. J. Immunol. 169 (2002) 1014-1020
174. Le Trong H., Neurath H., and Woodbury R.G. Substrate specificity of the chymotrypsin-like protease in secretory granules isolated from rat mast cells [published erratum appears in Proc. Natl. Acad. Sci. USA (1987 Apr) 84(8), 2266]. Proc. Natl. Acad. Sci. USA 84 (1987) 364-367
175. Le Trong H., Parmelee D.C., Walsh K.A., Neurath H., and Woodbury R.G. Amino acid sequence of rat mast cell protease I (chymase). Biochemistry 26 (1987) 6988-6994
176. Lee D.M., Friend D.S., Gurish M.F., Benoist C., Mathis D., and Brenner M.B. Mast cells: A cellular link between autoantibodies and inflammatory arthritis. Science 297 (2002) 1689-1692
177. Lee M., Calabresi L., Chiesa G., Franceschini G., and Kovanen P.T. Mast cell chymase degrades apoE and apoA-II in apoA-I-knockout mouse plasma and reduces its ability to promote cellular cholesterol efflux. Arterioscler. Thromb. Vasc. Biol. 22 (2002) 1475-1481
178. Lee M., Sommerhoff C.P., von Eckardstein A., Zettl F., Fritz H., and Kovanen P.T. Mast cell tryptase degrades HDL and blocks its function as an acceptor of cellular cholesterol. Arterioscler. Thromb. Vasc. Biol. 22 (2002) 2086-2091
179. Lee M., Kovanen P.T., Tedeschi G., Oungre E., Franceschini G., and Calabresi L. Apolipoprotein composition and particle size affect HDL degradation by chymase: Effect on cellular cholesterol efflux. J. Lipid Res. 44 (2003) 539-546
180. Lee M., Metso J., Jauhiainen M., and Kovanen P.T. Degradation of phospholipid transfer protein (PLTP) and PLTP-generated pre-beta-high density lipoprotein by mast cell chymase impairs high affinity efflux of cholesterol from macrophage foam cells. J. Biol. Chem. 278 (2003) 13539-13545
181. Lee-Rueckert M., and Kovanen P.T. Mast cell proteases: Physiological tools to study functional significance of high density lipoproteins in the initiation of reverse cholesterol transport. Atherosclerosis 189 (2006) 8-18
182. Lees M., Taylor D.J., and Woolley D.E. Mast cell proteinases activate precursor forms of collagenase and stromelysin, but not of gelatinases A and B. Eur. J. Biochem. 223 (1994) 171-177
183. Leskinen M., Wang Y., Leszczynski D., Lindstedt K.A., and Kovanen P.T. Mast cell chymase induces apoptosis of vascular smooth muscle cells. Arterioscler. Thromb. Vasc. Biol. 21 (2001) 516-522
184. Leskinen M.J., Lindstedt K.A., Wang Y., and Kovanen P.T. Mast cell chymase induces smooth muscle cell apoptosis by a mechanism involving fibronectin degradation and disruption of focal adhesions. Arterioscler. Thromb. Vasc. Biol. 23 (2003) 238-243
185. Leskinen M.J., Heikkila H.M., Speer M.Y., Hakala J.K., Laine M., Kovanen P.T., and Lindstedt K.A. Mast cell chymase induces smooth muscle cell apoptosis by disrupting NF-kappaB-mediated survival signaling. Exp. Cell Res. 312 (2006) 1289-1298
186. Levi-Schaffer F., and Piliponsky A.M. Tryptase, a novel link between allergic inflammation and fibrosis. Trends Immunol. 24 (2003) 158-161
187. Li L., Li Y., Reddel S.W., Cherrian M., Friend D.S., Stevens R.L., and Krilis S.A. Identification of basophilic cells that express mast cell granule proteases in the peripheral blood of asthma, allergy, and drug-reactive patients. J. Immunol. 161 (1998) 5079-5086
188. Li M., Liu K., Michalicek J., Angus J.A., Hunt J.E., Dell'Italia L.J., Feneley M.P., Graham R.M., and Husain A. Involvement of chymase-mediated angiotensin II generation in blood pressure regulation. J. Clin. Invest. 114 (2004) 112-120
189. Lindstedt K.A., Wang Y., Shiota N., Saarinen J., Hyytiainen M., Kokkonen J.O., Keski-Oja J., and Kovanen P.T. Activation of paracrine TGF-beta1 signaling upon stimulation and degranulation of rat serosal mast cells: A novel function for chymase. FASEB J. 15 (2001) 1377-1388
190. Lindstedt L., Lee M., Castro G.R., Fruchart J.C., and Kovanen P.T. Chymase in exocytosed rat mast cell granules effectively proteolyzes apolipoprotein AI-containing lipoproteins, so reducing the cholesterol efflux-inducing ability of serum and aortic intimal fluid. J. Clin. Invest. 97 (1996) 2174-2182
191. Lindstedt L., Lee M., and Kovanen P.T. Chymase bound to heparin is resistant to its natural inhibitors and capable of proteolyzing high density lipoproteins in aortic intimal fluid. Atherosclerosis 155 (2001) 87-97
192. Lohi J., Harvima I., and Keski-Oja J. Pericellular substrates of human mast cell tryptase: 72,000 dalton gelatinase and fibronectin. J. Cell. Biochem. 50 (1992) 337-349
193. Longley B.J., Tyrrell L., Ma Y., Williams D.A., Halaban R., Langley K., Lu H.S., and Schechter N.M. Chymase cleavage of stem cell factor yields a bioactive, soluble product. Proc. Natl. Acad. Sci. USA 94 (1997) 9017-9021
194. Lundequist A., Juliano M.A., Juliano L., and Pejler G. Polycationic peptides as inhibitors of mast cell serine proteases. Biochem. Pharmacol. 65 (2003) 1171-1180
195. Lundequist A., Tchougounova E., Åbrink M., and Pejler G. Cooperation between mast cell carboxypeptidase A and the chymase mouse mast cell protease 4 in the formation and degradation of angiotensin II. J. Biol. Chem. 279 (2004) 32339-32344
196. Lundequist A., Åbrink M., and Pejler G. Mast cell-dependent activation of pro matrix metalloprotease 2: A role for serglycin proteoglycan-dependent mast cell proteases. Biol. Chem. 387 (2006) 1513-1519
197. Lunderius C., and Hellman L. Characterization of the gene encoding mouse mast cell protease 8 (mMCP-8), and a comparative analysis of hematopoietic serine protease genes. Immunogenetics 53 (2001) 225-232
198. Lützelschwab C., Pejler G., Aveskogh M., and Hellman L. Secretory granule proteases in rat mast cells. Cloning of 10 different serine proteases and a carboxypeptidase A from various rat mast cell populations. J. Exp. Med. 185 (1997) 13-29
199. Lützelschwab C., Lunderius C., Enerback L., and Hellman L. A kinetic analysis of the expression of mast cell protease mRNA in the intestines of Nippostrongylus brasiliensis-infected rats. Eur. J. Immunol. 28 (1998) 3730-3737
200. Macaldowie C.N., Mackellar A., and Huntley J.F. The isolation and purification of a dual specific mast cell-derived protease from parasitised caprine jejunal tissue. Res. Vet. Sci. 64 (1998) 17-24
201. Maccarana M., and Lindahl U. Mode of interaction between platelet factor 4 and heparin. Glycobiology 3 (1993) 271-277
202. Malaviya R., Ikeda T., Ross E., and Abraham S.N. Mast cell modulation of neutrophil influx and bacterial clearance at sites of infection through TNF-alpha [see comments]. Nature 381 (1996) 77-80
203. Mallen-St Clair J., Pham C.T., Villalta S.A., Caughey G.H., and Wolters P.J. Mast cell dipeptidyl peptidase I mediates survival from sepsis. J. Clin. Invest. 113 (2004) 628-634
204. Mao X.Q., Shirakawa T., Yoshikawa T., Yoshikawa K., Kawai M., Sasaki S., Enomoto T., Hashimoto T., Furuyama J., Hopkin J.M., and Morimoto K. Association between genetic variants of mast-cell chymase and eczema [see comments] [published erratum appears in Lancet (1997 Jan 4) 349(9044), 64]. Lancet 348 (1996) 581-583
205. Mao X.Q., Shirakawa T., Enomoto T., Shimazu S., Dake Y., Kitano H., Hagihara A., and Hopkin J.M. Association between variants of mast cell chymase gene and serum IgE levels in eczema [published erratum appears in Hum. Hered. (1998 Mar-Apr) 48(2), 91]. Hum. Hered. 48 (1998) 38-41
206. Marquardt U., Zettl F., Huber R., Bode W., and Sommerhoff C. The crystal structure of human alpha1-tryptase reveals a blocked substrate-binding region. J. Mol. Biol. 321 (2002) 491-502
207. Maruichi M., Takai S., Sugiyama T., Ueki M., Oku H., Sakaguchi M., Okamoto Y., Muramatsu M., Ikeda T., and Miyazaki M. Role of chymase on growth of cultured canine Tenon's capsule fibroblasts and scarring in a canine conjunctival flap model. Exp. Eye Res. 79 (2004) 111-118
208. Masaki H., Mizuno Y., Tatui A., Murakami A., Koide Y., Satoh S., and Takahashi A. Structure-activity relationship of benzo[b]thiophene-2-sulfonamide derivatives as novel human chymase inhibitors. Bioorg. Med. Chem. Lett. 13 (2003) 4085-4088
209. Matin R., Tam E.K., Nadel J.A., and Caughey G.H. Distribution of chymase-containing mast cells in human bronchi. J. Histochem. Cytochem. 40 (1992) 781-786
210. Matsumoto R., Sali A., Ghildyal N., Karplus M., and Stevens R.L. Packaging of proteases and proteoglycans in the granules of mast cells and other hematopoietic cells. A cluster of histidines on mouse mast cell protease 7 regulates its binding to heparin serglycin proteoglycans. J. Biol. Chem. 270 (1995) 19524-19531
211. Matsuo T., Ikura Y., Ohsawa M., Ogami M., Kayo S., Yoshimi N., Hai E., Naruko T., Ohishi M., Higuchi K., Arakawa T., and Ueda M. Mast cell chymase expression in Helicobacter pylori-associated gastritis. Histopathology 43 (2003) 538-549
212. McAleese S.M., Pemberton A.D., McGrath M.E., Huntley J.F., and Miller H.R. Sheep mast-cell proteinases-1 and -3: cDNA cloning, primary structure and molecular modelling of the enzymes and further studies on substrate specificity. Biochem. J. 333 (1998) 801-809
213. McDermott J.R., Bartram R.E., Knight P.A., Miller H.R., Garrod D.R., and Grencis R.K. Mast cells disrupt epithelial barrier function during enteric nematode infection. Proc. Natl. Acad. Sci. USA 100 (2003) 7761-7766
214. McEuen A.R., Ashworth D.M., and Walls A.F. The conversion of recombinant human mast cell prochymase to enzymatically active chymase by dipeptidyl peptidase I is inhibited by heparin and histamine. Eur. J. Biochem. 253 (1998) 300-308
215. McGrath M.E., Mirzadegan T., and Schmidt B.F. Crystal structure of phenylmethanesulfonyl fluoride-treated human chymase at 1.9 Å. Biochemistry 36 (1997) 14318-14324
216. McNeil H.P., Reynolds D.S., Schiller V., Ghildyal N., Gurley D.S., Austen K.F., and Stevens R.L. Isolation, characterization, and transcription of the gene encoding mouse mast cell protease 7. Proc. Natl. Acad. Sci. USA 89 (1992) 11174-11178
217. Metcalfe D.D., Baram D., and Mekori Y.A. Mast cells. Physiol. Rev. 77 (1997) 1033-1079
218. Metsarinne K.P., Vehmaan-Kreula P., Kovanen P.T., Saijonmaa O., Baumann M., Wang Y., Nyman T., Fyhrquist F.Y., and Eklund K.K. Activated mast cells increase the level of endothelin-1 mRNA in cocultured endothelial cells and degrade the secreted peptide. Arterioscler. Thromb. Vasc. Biol. 22 (2002) 268-273
219. Metz M., Piliponsky A.M., Chen C.C., Lammel V., Abrink M., Pejler G., Tsai M., and Galli S.J. Mast cells can enhance resistance to snake and honeybee venoms. Science 313 (2006) 526-530
220. Miller H.R., Wright S.H., Knight P.A., and Thornton E.M. A novel function for transforming growth factor-beta1: Upregulation of the expression and the IgE-independent extracellular release of a mucosal mast cell granule-specific beta-chymase, mouse mast cell protease-1. Blood 93 (1999) 3473-3486
221. Miller J.S., Westin E.H., and Schwartz L.B. Cloning and characterization of complementary DNA for human tryptase. J. Clin. Invest. 84 (1989) 1188-1195
222. Miller J.S., Moxley G., and Schwartz L.B. Cloning and characterization of a second complementary DNA for human tryptase. J. Clin. Invest. 86 (1990) 864-870
223. Mirza H., Schmidt V.A., Derian C.K., Jesty J., and Bahou W.F. Mitogenic responses mediated through the proteinase-activated receptor- 2 are induced by expressed forms of mast cell alpha- or beta-tryptases. Blood 90 (1997) 3914-3922
224. Mizutani H., Schechter N., Lazarus G., Black R.A., and Kupper T.S. Rapid and specific conversion of precursor interleukin 1 beta (IL-1 beta) to an active IL-1 species by human mast cell chymase. J. Exp. Med. 174 (1991) 821-825
225. Molinari J.F., Moore W.R., Clark J., Tanaka R., Butterfield J.H., and Abraham W.M. Role of tryptase in immediate cutaneous responses in allergic sheep. J. Appl. Physiol. 79 (1995) 1966-1970
226. Molinari J.F., Scuri M., Moore W.R., Clark J., Tanaka R., and Abraham W.M. Inhaled tryptase causes bronchoconstriction in sheep via histamine release. Am. J. Respir. Crit. Care Med. 154 (1996) 649-653
227. Molino M., Barnathan E.S., Numerof R., Clark J., Dreyer M., Cumashi A., Hoxie J.A., Schechter N., Woolkalis M., and Brass L.F. Interactions of mast cell tryptase with thrombin receptors and PAR-2. J. Biol. Chem. 272 (1997) 4043-4049
228. Morii E., Takebayashi K., Motohashi H., Yamamoto M., Nomura S., and Kitamura Y. Loss of DNA binding ability of the transcription factor encoded by the mutant mi locus. Biochem. Biophys. Res. Commun. 205 (1994) 1299-1304
229. Morii E., Tsujimura T., Jippo T., Hashimoto K., Takebayashi K., Tsujino K., Nomura S., Yamamoto M., and Kitamura Y. Regulation of mouse mast cell protease 6 gene expression by transcription factor encoded by the mi locus. Blood 88 (1996) 2488-2494
230. Morii E., Jippo T., Tsujimura T., Hashimoto K., Kim D.K., Lee Y.M., Ogihara H., Tsujino K., Kim H.M., and Kitamura Y. Abnormal expression of mouse mast cell protease 5 gene in cultured mast cells derived from mutant mi/mi mice. Blood 90 (1997) 3057-3066
231. Morii E., Ogihara H., Kim D.K., Ito A., Oboki K., Lee Y.M., Jippo T., Nomura S., Maeyama K., Lamoreux M.L., and Kitamura Y. Importance of leucine zipper domain of mi transcription factor (MITF) for differentiation of mast cells demonstrated using mi(ce)/mi(ce) mutant mice of which MITF lacks the zipper domain. Blood 97 (2001) 2038-2044
232. Morii E., Ogihara H., Oboki K., Kataoka T.R., Jippo T., and Kitamura Y. Effect of MITF on transcription of transmembrane tryptase gene in cultured mast cells of mice. Biochem. Biophys. Res. Commun. 289 (2001) 1243-1246
233. Morii E., Oboki K., Kataoka T.R., Igarashi K., and Kitamura Y. Interaction and cooperation of mi transcription factor (MITF) and myc-associated zinc-finger protein-related factor (MAZR) for transcription of mouse mast cell protease 6 gene. J. Biol. Chem. 277 (2002) 8566-8571
234. Murakami M., Karnik S.S., and Husain A. Human prochymase activation. A novel role for heparin in zymogen processing. J. Biol. Chem. 270 (1995) 2218-2223
235. Murakami Y., Takei M., Shindo K., Kitazume C., Tanaka J., Higa T., and Fukamachi H. Cyclotheonamide E4 and E5, new potent tryptase inhibitors from an Ircinia species of sponge. J. Nat. Prod. 65 (2002) 259-261
236. Muramatsu M., Katada J., Hattori M., Hayashi I., and Majima M. Chymase mediates mast cell-induced angiogenesis in hamster sponge granulomas. Eur. J. Pharmacol. 402 (2000) 181-191
237. Muramatsu M., Yamada M., Takai S., and Miyazaki M. Suppression of basic fibroblast growth factor-induced angiogenesis by a specific chymase inhibitor, BCEAB, through the chymase-angiotensin-dependent pathway in hamster sponge granulomas. Br. J. Pharmacol. 137 (2002) 554-560
238. Nagata M., Shijubo N., Walls A.F., Ichimiya S., Abe S., and Sato N. Chymase-positive mast cells in small sized adenocarcinoma of the lung. Virchows Arch. 443 (2003) 565-573
239. Nakajima M., and Naya N. Development of a chymase inhibitor: Pharmacological characterization of a chymase inhibitor in inflamed tissue remodeling and fibrosis. Jpn. J. Pharmacol. 90 (2002) 206-209
240. Nakano A., Kishi F., Minami K., Wakabayashi H., Nakaya Y., and Kido H. Selective conversion of big endothelins to tracheal smooth muscle- constricting 31-amino acid-length endothelins by chymase from human mast cells. J. Immunol. 159 (1997) 1987-1992
241. Namazi M.R. Possible molecular mechanisms to account for the involvement of tryptase in the pathogenesis of psoriasis. Autoimmunity 38 (2005) 449-452
242. Naukkarinen A., Harvima I.T., Aalto M.L., and Horsmanheimo M. Mast cell tryptase and chymase are potential regulators of neurogenic inflammation in psoriatic skin. Int. J. Dermatol. 33 (1994) 361-366
243. Nico B., Marzullo A., Corsi P., Vacca A., Roncali L., and Ribatti D. A possible role of tryptase in angiogenesis in the brain of mdx mouse, a model of Duchenne muscular dystrophy. Neuroscience 123 (2004) 585-588
244. Nishikori Y., Kakizoe E., Kobayashi Y., Shimoura K., Okunishi H., and Dekio S. Skin mast cell promotion of matrix remodeling in burn wound healing in mice: Relevance of chymase. Arch. Dermatol. Res. 290 (1998) 553-560
245. Niwata S., Fukami H., Sumida M., Ito A., Kakutani S., Saitoh M., Suzuki K., Imoto M., Shibata H., Imajo S., Kiso Y., Tanaka T., et al. Substituted 3-(phenylsulfonyl)-1-phenylimidazolidine-2,4-dione derivatives as novel nonpeptide inhibitors of human heart chymase. J. Med. Chem. 40 (1997) 2156-2163
246. Normant E., Martres M.P., Schwartz J.C., and Gros C. Purification, cDNA cloning, functional expression, and characterization of a 26-kDa endogenous mammalian carboxypeptidase inhibitor. Proc. Natl. Acad. Sci. USA 92 (1995) 12225-12229
247. Ogihara H., Kanno T., Morii E., Kim D.K., Lee Y.M., Sato M., Kim W.Y., Nomura S., Ito Y., and Kitamura Y. Synergy of PEBP2/CBF with mi transcription factor (MITF) for transactivation of mouse mast cell protease 6 gene. Oncogene 18 (1999) 4632-4639
248. Ogihara H., Morii E., Kim D.K., Oboki K., and Kitamura Y. Inhibitory effect of the transcription factor encoded by the mutant mi microphthalmia allele on transactivation of mouse mast cell protease 7 gene. Blood 97 (2001) 645-651
249. Oh S.W., Pae C.I., Lee D.K., Jones F., Chiang G.K., Kim H.O., Moon S.H., Cao B., Ogbu C., Jeong K.W., Kozu G., Nakanishi H., et al. Tryptase inhibition blocks airway inflammation in a mouse asthma model. J. Immunol. 168 (2002) 1992-2000
250. Ohtsu H., Tanaka S., Terui T., Hori Y., Makabe-Kobayashi Y., Pejler G., Tchougounova E., Hellman L., Gertsenstein M., Hirasawa N., Sakurai E., Buzas E., et al. Mice lacking histidine decarboxylase exhibit abnormal mast cells. FEBS Lett. 502 (2001) 53-56
251. Okamoto Y., Takai S., and Miyazaki M. Chymase inhibitor, BCEAB, suppressed peritoneal adhesion formation in hamster. J. Surg. Res. 107 (2002) 219-222
252. Okamoto Y., Takai S., and Miyazaki M. Oral administration of a novel chymase inhibitor, NK3201, prevents peritoneal adhesion formation in hamsters. Jpn. J. Pharmacol. 90 (2002) 94-96
253. Okamoto Y., Takai S., and Miyazaki M. Effect of chymase-dependent transforming growth factor beta on peritoneal adhesion formation in a rat model. Surg. Today 34 (2004) 865-867
254. Okamoto Y., Takai S., and Miyazaki M. Significance of chymase inhibition for prevention of adhesion formation. Eur. J. Pharmacol. 484 (2004) 357-359
255. Okumura K., Takai S., Muramatsu M., Katayama S., Sakaguchi M., Kishi K., Jin D., and Miyazaki M. Human chymase degrades human fibronectin. Clin. Chim. Acta 347 (2004) 223-225
256. Omoto Y., Tokime K., Yamanaka K., Habe K., Morioka T., Kurokawa I., Tsutsui H., Yamanishi K., Nakanishi K., and Mizutani H. Human mast cell chymase cleaves pro-IL-18 and generates a novel and biologically active IL-18 fragment. J. Immunol. 177 (2006) 8315-8319
257. Ortlepp J.R., Janssens U., Bleckmann F., Lauscher J., Merkelbach-Bruse S., Hanrath P., and Hoffmann R. A chymase gene variant is associated with atherosclerosis in venous coronary artery bypass grafts. Coron. Artery Dis. 12 (2001) 493-497
258. Ossovskaya V.S., and Bunnett N.W. Protease-activated receptors: Contribution to physiology and disease. Physiol. Rev. 84 (2004) 579-621
259. Padmanabhan N., Jardine A.G., McGrath J.C., and Connell J.M. Angiotensin-converting enzyme-independent contraction to angiotensin I in human resistance arteries. Circulation 99 (1999) 2914-2920
260. Pallaoro M., Fejzo M.S., Shayesteh L., Blount J.L., and Caughey G.H. Characterization of genes encoding known and novel human mast cell tryptases on chromosome 16p13.3. J. Biol. Chem. 274 (1999) 3355-3362
261. Pang L., Nie M., Corbett L., Sutcliffe A., and Knox A.J. Mast cell beta-tryptase selectively cleaves eotaxin and RANTES and abrogates their eosinophil chemotactic activities. J. Immunol. 176 (2006) 3788-3795
262. Pedotti R., De Voss J.J., Steinman L., and Galli S.J. Involvement of both 'allergic' and 'autoimmune' mechanisms in EAE, MS and other autoimmune diseases. Trends Immunol. 24 (2003) 479-484
263. Pedotti R., DeVoss J.J., Youssef S., Mitchell D., Wedemeyer J., Madanat R., Garren H., Fontoura P., Tsai M., Galli S.J., Sobel R.A., Steinman L., et al. Multiple elements of the allergic arm of the immune response modulate autoimmune demyelination. Proc. Natl. Acad. Sci. USA 100 (2003) 1867-1872
264. Pejler G. Mast cell chymase in complex with heparin proteoglycan is regulated by protamine. FEBS Lett. 383 (1996) 170-174
265. Pejler G., and Berg L. Regulation of rat mast cell protease 1 activity. Protease inhibition is prevented by heparin proteoglycan. Eur. J. Biochem. 233 (1995) 192-199
266. Pejler G., and Karlstrom A. Thrombin is inactivated by mast cell secretory granule chymase. J. Biol. Chem. 268 (1993) 11817-11822
267. Pejler G., and Maccarana M. Interaction of heparin with rat mast cell protease 1. J. Biol. Chem. 269 (1994) 14451-14456
268. Pejler G., and Sadler J.E. Mechanism by which heparin proteoglycan modulates mast cell chymase activity. Biochemistry 38 (1999) 12187-12195
269. Pejler G., Soderstrom K., and Karlstrom A. Inactivation of thrombin by a complex between rat mast-cell protease 1 and heparin proteoglycan. Biochem. J. 299 Pt. 2 (1994) 507-513
270. Pejler G., Karlström A.R., and Berg L. Identification of the proteolytic thrombin fragments formed after cleavage with rat mast cell protease 1. Eur. J. Biochem. 227 (1995) 102-107
271. Pemberton A.D., Belham C.M., Huntley J.F., Plevin R., and Miller H.R. Sheep mast cell proteinase-1, a serine proteinase with both tryptase- and chymase-like properties, is inhibited by plasma proteinase inhibitors and is mitogenic for bovine pulmonary artery fibroblasts. Biochem. J. 323 (1997) 719-725
272. Pemberton A.D., McAleese S.M., Huntley J.F., Collie D.D., Scudamore C.L., McEuen A.R., Walls A.F., and Miller H.R. cDNA sequence of two sheep mast cell tryptases and the differential expression of tryptase and sheep mast cell proteinase-1 in lung, dermis and gastrointestinal tract. Clin. Exp. Allergy 30 (2000) 818-832
273. Pemberton A.D., Wright S.H., Knight P.A., and Miller H.R. Anaphylactic release of mucosal mast cell granule proteases: Role of serpins in the differential clearance of mouse mast cell proteases-1 and -2. J. Immunol. 176 (2006) 899-904
274. Pereira P.J., Bergner A., Macedo-Ribeiro S., Huber R., Matschiner G., Fritz H., Sommerhoff C.P., and Bode W. Human beta-tryptase is a ring-like tetramer with active sites facing a central pore. Nature 392 (1998) 306-311
275. Pereira P.J.B., Wang Z.M., Rubin H., Huber R., Bode W., Schechter N.M., and Strobl S. The 2.2 # crystal structure of human chymase in complex with succinyl- Ala-Ala-Pro-Phe-chloromethylketone: Structural explanation for its dipeptidyl carboxypeptidase specificity. J. Mol. Biol. 286 (1999) 163-173
276. Pfeufer A., Osterziel K.J., Urata H., Borck G., Schuster H., Wienker T., Dietz R., and Luft F.C. Angiotensin-converting enzyme and heart chymase gene polymorphisms in hypertrophic cardiomyopathy. Am. J. Cardiol. 78 (1996) 362-364
277. Poorafshar M., Aveskogh M., Munday B., and Hellman L. Identification and structural analysis of four serine proteases in a monotreme, the platypus, Ornithorhynchus anatinus. Immunogenetics 52 (2000) 19-28
278. Poorafshar M., Helmby H., Troye-Blomberg M., and Hellman L. MMCP-8, the first lineage-specific differentiation marker for mouse basophils. Elevated numbers of potent IL-4-producing and MMCP-8-positive cells in spleens of malaria-infected mice. Eur. J. Immunol. 30 (2000) 2660-2668
279. Powers J.C., Tanaka T., Harper J.W., Minematsu Y., Barker L., Lincoln D., Crumley K.V., Fraki J.E., Schechter N.M., Lazarus G.G., Nakajima K., Nakashino K., et al. Mammalian chymotrypsin-like enzymes. Comparative reactivities of rat mast cell proteases, human and dog skin chymases, and human cathepsin G with peptide 4-nitroanilide substrates and with peptide chloromethyl ketone and sulfonyl fluoride inhibitors. Biochemistry 24 (1985) 2048-2058
280. Prasad P., Tiwari A.K., Kumar K.M., Ammini A.C., Gupta A., Gupta R., Sharma A.K., Rao A.R., Nagendra R., Chandra T.S., Tiwari S.C., Rastogi P., et al. Chronic renal insufficiency among Asian Indians with type 2 diabetes: I. Role of RAAS gene polymorphisms. BMC Med. Genet. 7 (2006) 42
281. Praveen K., Evans D.L., and Jaso-Friedmann L. Evidence for the existence of granzyme-like serine proteases in teleost cytotoxic cells. J. Mol. Evol. 58 (2004) 449-459
282. Praveen K., Leary III J.H., Evans D.L., and Jaso-Friedmann L. Nonspecific cytotoxic cells of teleosts are armed with multiple granzymes and other components of the granule exocytosis pathway. Mol. Immunol. 43 (2006) 1152-1162
283. Rath-Wolfson L. An immunocytochemical approach to the demonstration of intracellular processing of mast cell carboxypeptidase. Appl. Immunohistochem. Mol. Morphol. 9 (2001) 81-85
284. Raymond W.W., Ruggles S.W., Craik C.S., and Caughey G.H. Albumin is a substrate of human chymase. Prediction by combinatorial peptide screening and development of a selective inhibitor based on the albumin cleavage site. J. Biol. Chem. 278 (2003) 34517-34524
285. Raymond W.W., Sommerhoff C.P., and Caughey G.H. Mastin is a gelatinolytic mast cell peptidase resembling a mini-proteasome. Arch. Biochem. Biophys. 435 (2005) 311-322
286. Raymond W.W., Cruz A.C., and Caughey G.H. Mast cell and neutrophil peptidases attack an inactivation segment in hepatocyte growth factor to generate NK4-like antagonists. J. Biol. Chem. 281 (2006) 1489-1494
287. Razin E., Stevens R.L., Akiyama F., Schmid K., and Austen K.F. Culture from mouse bone marrow of a subclass of mast cells possessing a distinct chondroitin sulfate proteoglycan with glycosaminoglycans rich in N-acetylgalactosamine-4,6-disulfate. J. Biol. Chem. 257 (1982) 7229-7236
288. Reiling K.K., Krucinski J., Miercke L.J., Raymond W.W., Caughey G.H., and Stroud R.M. Structure of human pro-chymase: A model for the activating transition of granule-associated proteases. Biochemistry 42 (2003) 2616-2624
289. Reilly C.F., Tewksbury D.A., Schechter N.M., and Travis J. Rapid conversion of angiotensin I to angiotensin II by neutrophil and mast cell proteinases. J. Biol. Chem. 257 (1982) 8619-8622
290. Reilly C.F., Schechter N.B., and Travis J. Inactivation of bradykinin and kallidin by cathepsin G and mast cell chymase. Biochem. Biophys. Res. Commun. 127 (1985) 443-449
291. Remington S.J., Woodbury R.G., Reynolds R.A., Matthews B.W., and Neurath H. The structure of rat mast cell protease II at 1.9-A resolution. Biochemistry 27 (1988) 8097-8105
292. Reynolds D.S., Gurley D.S., Stevens R.L., Sugarbaker D.J., Austen K.F., and Serafin W.E. Cloning of cDNAs that encode human mast cell carboxypeptidase A, and comparison of the protein with mouse mast cell carboxypeptidase A and rat pancreatic carboxypeptidases. Proc. Natl. Acad. Sci. USA 86 (1989) 9480-9484
293. Reynolds D.S., Stevens R.L., Gurley D.S., Lane W.S., Austen K.F., and Serafin W.E. Isolation and molecular cloning of mast cell carboxypeptidase A. A novel member of the carboxypeptidase gene family. J. Biol. Chem. 264 (1989) 20094-20099
294. Reynolds D.S., Stevens R.L., Lane W.S., Carr M.H., Austen K.F., and Serafin W.E. Different mouse mast cell populations express various combinations of at least six distinct mast cell serine proteases. Proc. Natl. Acad. Sci. USA 87 (1990) 3230-3234
295. Reynolds D.S., Gurley D.S., Austen K.F., and Serafin W.E. Cloning of the cDNA and gene of mouse mast cell protease-6. Transcription by progenitor mast cells and mast cells of the connective tissue subclass. J. Biol. Chem. 266 (1991) 3847-3853
296. Reynolds D.S., Gurley D.S., and Austen K.F. Cloning and characterization of the novel gene for mast cell carboxypeptidase A. J. Clin. Invest. 89 (1992) 273-282
297. Rice K.D., Tanaka R.D., Katz B.A., Numerof R.P., and Moore W.R. Inhibitors of tryptase for the treatment of mast cell-mediated diseases. Curr. Pharm. Des. 4 (1998) 381-396
298. Rice K.D., Gangloff A.R., Kuo E.Y., Dener J.M., Wang V.R., Lum R., Newcomb W.S., Havel C., Putnam D., Cregar L., Wong M., and Warne R.L. Dibasic inhibitors of human mast cell tryptase. Part 1: Synthesis and optimization of a novel class of inhibitors. Bioorg. Med. Chem. Lett. 10 (2000) 2357-2360
299. Rice K.D., Wang V.R., Gangloff A.R., Kuo E.Y., Dener J.M., Newcomb W.S., Young W.B., Putnam D., Cregar L., Wong M., and Simpson P.J. Dibasic inhibitors of human mast cell tryptase. Part 2: Structure-activity relationships and requirements for potent activity. Bioorg. Med. Chem. Lett. 10 (2000) 2361-2366
300. Richard V., Hurel-Merle S., Scalbert E., Ferry G., Lallemand F., Bessou J.P., and Thuillez C. Functional evidence for a role of vascular chymase in the production of angiotensin II in isolated human arteries. Circulation 104 (2001) 750-752
301. Rodewald H.R., Dessing M., Dvorak A.M., and Galli S.J. Identification of a committed precursor for the mast cell lineage. Science 271 (1996) 818-822
302. Rozniecki J.J., Hauser S.L., Stein M., Lincoln R., and Theoharides T.C. Elevated mast cell tryptase in cerebrospinal fluid of multiple sclerosis patients. Ann. Neurol. 37 (1995) 63-66
303. Rubinstein I., Nadel J.A., Graf P.D., and Caughey G.H. Mast cell chymase potentiates histamine-induced wheal formation in the skin of ragweed-allergic dogs. J. Clin. Invest. 86 (1990) 555-559
304. Ruoss S.J., Hartmann T., and Caughey G.H. Mast cell tryptase is a mitogen for cultured fibroblasts. J. Clin. Invest. 88 (1991) 493-499
305. Russo A., Russo G., Peticca M., Pietropaolo C., Di Rosa M., and Iuvone T. Inhibition of granuloma-associated angiogenesis by controlling mast cell mediator release: Role of mast cell protease-5. Br. J. Pharmacol. 145 (2005) 24-33
306. Saarinen J., Kalkkinen N., Welgus H.G., and Kovanen P.T. Activation of human interstitial procollagenase through direct cleavage of the Leu83-Thr84 bond by mast cell chymase. J. Biol. Chem. 269 (1994) 18134-18140
307. Sakaguchi M., Takai S., Jin D., Okamoto Y., Muramatsu M., Kim S., and Miyazaki M. A specific chymase inhibitor, NK3201, suppresses bleomycin-induced pulmonary fibrosis in hamsters. Eur. J. Pharmacol. 493 (2004) 173-176
308. Sakai K., Long S.D., Pettit D.A., Cabral G.A., and Schwartz L.B. Expression and purification of recombinant human tryptase in a baculovirus system. Protein Expr. Purif. 7 (1996) 67-73
309. Sakai K., Ren S., and Schwartz L.B. A novel heparin-dependent processing pathway for human tryptase. Autocatalysis followed by activation with dipeptidyl peptidase I [see comments]. J. Clin. Invest. 97 (1996) 988-995
310. Sali A., Matsumoto R., McNeil H.P., Karplus M., and Stevens R.L. Three-dimensional models of four mouse mast cell chymases. Identification of proteoglycan binding regions and protease-specific antigenic epitopes. J. Biol. Chem. 268 (1993) 9023-9034
311. Sanker S., Chandrasekharan U.M., Wilk D., Glynias M.J., Karnik S.S., and Husain A. Distinct multisite synergistic interactions determine substrate specificities of human chymase and rat chymase-1 for angiotensin II formation and degradation. J. Biol. Chem. 272 (1997) 2963-2968
312. Satomura K., Yin M., Shimizu S., Kato Y., Nagano T., Komeichi H., Ohsuga M., Katsuta Y., Aramaki T., and Omoto Y. Increased chymase in livers with autoimmune disease: Colocalization with fibrosis. J. Nippon Med. Sch. 70 (2003) 490-495
313. Sayama S., Iozzo R.V., Lazarus G.S., and Schechter N.M. Human skin chymotrypsin-like proteinase chymase. Subcellular localization to mast cell granules and interaction with heparin and other glycosaminoglycans. J. Biol. Chem. 262 (1987) 6808-6815
314. Schaschke N., Dominik A., Matschiner G., and Sommerhoff C.P. Bivalent inhibition of beta-tryptase: Distance scan of neighboring subunits by dibasic inhibitors. Bioorg. Med. Chem. Lett. 12 (2002) 985-988
315. Schechter I., and Berger A. On the size of the active site in proteases. I. Papain. Biochem. Biophys. Res. Commun. 27 (1967) 157-162
316. Schechter N.M., Sprows J.L., Schoenberger O.L., Lazarus G.S., Cooperman B.S., and Rubin H. Reaction of human skin chymotrypsin-like proteinase chymase with plasma proteinase inhibitors. J. Biol. Chem. 264 (1989) 21308-21315
317. Schechter N.M., Irani A.M., Sprows J.L., Abernethy J., Wintroub B., and Schwartz L.B. Identification of a cathepsin G-like proteinase in the MCTC type of human mast cell. J. Immunol. 145 (1990) 2652-2661
318. Schechter N.M., Wang Z.M., Blacher R.W., Lessin S.R., Lazarus G.S., and Rubin H. Determination of the primary structures of human skin chymase and cathepsin G from cutaneous mast cells of urticaria pigmentosa lesions. J. Immunol. 152 (1994) 4062-4069
319. Schechter N.M., Brass L.F., Lavker R.M., and Jensen P.J. Reaction of mast cell proteases tryptase and chymase with protease activated receptors (PARs) on keratinocytes and fibroblasts. J. Cell. Physiol. 176 (1998) 365-373
320. Schick B., and Austen K.F. Rat serosal mast cell degranulation mediated by chymase, an endogenous secretory granule protease: Active site-dependent initiation at 1 degree C. J. Immunol. 136 (1986) 3812-3818
321. Schick B., Austen K.F., and Schwartz L.B. Activation of rat serosal mast cells by chymase, an endogenous secretory granule protease. J. Immunol. 132 (1984) 2571-2577
322. Schick C., Kamachi Y., Bartuski A.J., Cataltepe S., Schechter N.M., Pemberton P.A., and Silverman G.A. Squamous cell carcinoma antigen 2 is a novel serpin that inhibits the chymotrypsin-like proteinases cathepsin G and mast cell chymase. J. Biol. Chem. 272 (1997) 1849-1855
323. Schiemann F., Grimm T.A., Hoch J., Gross R., Lindner B., Petersen F., Bulfone-Paus S., and Brandt E. Mast cells and neutrophils proteolytically activate chemokine precursor CTAP-III and are subject to counterregulation by PF-4 through inhibition of chymase and cathepsin G. Blood 107 (2006) 2234-2242
324. Schoenberger O.L., Sprows J.L., Schechter N.M., Cooperman B.S., and Rubin H. Limited proteolysis of C1-inhibitor by chymotrypsin-like proteinases. FEBS Lett. 259 (1989) 165-167
325. Schwartz L.B., and Austen K.F. Enzymes of the mast cell granule. J. Invest. Dermatol. 74 (1980) 349-353
326. Schwartz L.B., and Bradford T.R. Regulation of tryptase from human lung mast cells by heparin. Stabilization of the active tetramer. J. Biol. Chem. 261 (1986) 7372-7379
327. Schwartz L.B., Lewis R.A., and Austen K.F. Tryptase from human pulmonary mast cells. Purification and characterization. J. Biol. Chem. 256 (1981) 11939-11943
328. Schwartz L.B., Riedel C., Caulfield J.P., Wasserman S.I., and Austen K.F. Cell association of complexes of chymase, heparin proteoglycan, and protein after degranulation by rat mast cells. J. Immunol. 126 (1981) 2071-2078
329. Schwartz L.B., Bradford T.R., Littman B.H., and Wintroub B.U. The fibrinogenolytic activity of purified tryptase from human lung mast cells. J. Immunol. 135 (1985) 2762-2767
330. Schwartz L.B., Irani A.M., Roller K., Castells M.C., and Schechter N.M. Quantitation of histamine, tryptase, and chymase in dispersed human T and TC mast cells. J. Immunol. 138 (1987) 2611-2615
331. Scudamore C.L., Thornton E.M., McMillan L., Newlands G.F., and Miller H.R. Release of the mucosal mast cell granule chymase, rat mast cell protease-II, during anaphylaxis is associated with the rapid development of paracellular permeability to macromolecules in rat jejunum. J. Exp. Med. 182 (1995) 1871-1881
332. Scudamore C.L., Jepson M.A., Hirst B.H., and Miller H.R. The rat mucosal mast cell chymase, RMCP-II, alters epithelial cell monolayer permeability in association with altered distribution of the tight junction proteins ZO-1 and occludin. Eur. J. Cell Biol. 75 (1998) 321-330
333. Secor V.H., Secor W.E., Gutekunst C.A., and Brown M.A. Mast cells are essential for early onset and severe disease in a murine model of multiple sclerosis. J. Exp. Med. 191 (2000) 813-822
334. Sendo T., Itoh Y., Goromaru T., Sumimura T., Saito M., Aki K., Yano T., and Oishi R. A potent tryptase inhibitor nafamostat mesilate dramatically suppressed pulmonary dysfunction induced in rats by a radiographic contrast medium. Br. J. Pharmacol. 138 (2003) 959-967
335. Serafin W.E., Katz H.R., Austen K.F., and Stevens R.L. Complexes of heparin proteoglycans, chondroitin sulfate E proteoglycans, and [3H]diisopropyl fluorophosphate-binding proteins are exocytosed from activated mouse bone marrow-derived mast cells. J. Biol. Chem. 261 (1986) 15017-15021
336. Serafin W.E., Dayton E.T., Gravallese P.M., Austen K.F., and Stevens R.L. Carboxypeptidase A in mouse mast cells. Identification, characterization, and use as a differentiation marker. J. Immunol. 139 (1987) 3771-3776
337. Serafin W.E., Reynolds D.S., Rogelj S., Lane W.S., Conder G.A., Johnson S.S., Austen K.F., and Stevens R.L. Identification and molecular cloning of a novel mouse mucosal mast cell serine protease. J. Biol. Chem. 265 (1990) 423-429
338. Serafin W.E., Sullivan T.P., Conder G.A., Ebrahimi A., Marcham P., Johnson S.S., Austen K.F., and Reynolds D.S. Cloning of the cDNA and gene for mouse mast cell protease 4. Demonstration of its late transcription in mast cell subclasses and analysis of its homology to subclass-specific neutral proteases of the mouse and rat. J. Biol. Chem. 266 (1991) 1934-1941
339. Sheehan J.P., and Sadler J.E. Molecular mapping of the heparin-binding exosite of thrombin. Proc. Natl. Acad. Sci. USA 91 (1994) 5518-5522
340. Shimatani T., Hosotani N., Ohnishi M., Kumagai K., and Saji I. SPF-32629 A and B, novel human chymase inhibitors produced by Penicillium sp. J. Antibiot. (Tokyo) 59 (2006) 29-34
341. Shiota N., Kakizoe E., Shimoura K., Tanaka T., and Okunishi H. Effect of mast cell chymase inhibitor on the development of scleroderma in tight-skin mice. Br. J. Pharmacol. 145 (2005) 424-431
342. Silverman G.A., Whisstock J.C., Askew D.J., Pak S.C., Luke C.J., Cataltepe S., Irving J.A., and Bird P.I. Human clade B serpins (ov-serpins) belong to a cohort of evolutionarily dispersed intracellular proteinase inhibitor clades that protect cells from promiscuous proteolysis. Cell. Mol. Life Sci. 61 (2004) 301-325
343. Slusarchyk W.A., Bolton S.A., Hartl K.S., Huang M.H., Jacobs G., Meng W., Ogletree M.L., Pi Z., Schumacher W.A., Seiler S.M., Sutton J.C., Treuner U., et al. Synthesis of potent and highly selective inhibitors of human tryptase. Bioorg. Med. Chem. Lett. 12 (2002) 3235-3238
344. Smith T.J., Hougland M.W., and Johnson D.A. Human lung tryptase. Purification and characterization. J. Biol. Chem. 259 (1984) 11046-11051
345. Soga Y., Takai S., Koyama T., Okamoto Y., Ikeda T., Nishimura K., Miyazaki M., and Komeda M. Attenuation of adhesion formation after cardiac surgery with a chymase inhibitor in a hamster model. J. Thorac. Cardiovasc. Surg. 127 (2004) 72-78
346. Solivan S., Selwood T., Wang Z.M., and Schechter N.M. Evidence for diversity of substrate specificity among members of the chymase family of serine proteases. FEBS Lett. 512 (2002) 133-138
347. Somasundaram P., Ren G., Nagar H., Kraemer D., Mendoza L., Michael L.H., Caughey G.H., Entman M.L., and Frangogiannis N.G. Mast cell tryptase may modulate endothelial cell phenotype in healing myocardial infarcts. J. Pathol. 205 (2005) 102-111
348. Sommerhoff C.P., Caughey G.H., Finkbeiner W.E., Lazarus S.C., Basbaum C.B., and Nadel J.A. Mast cell chymase. A potent secretagogue for airway gland serous cells. J. Immunol. 142 (1989) 2450-2456
349. Sommerhoff C.P., Bode W., Matschiner G., Bergner A., and Fritz H. The human mast cell tryptase tetramer: A fascinating riddle solved by structure. Biochim. Biophys. Acta 1477 (2000) 75-89
350. Soto D., Malmsten C., Blount J.L., Muilenburg D.J., and Caughey G.H. Genetic deficiency of human mast cell alpha-tryptase. Clin. Exp. Allergy 32 (2002) 1000-1006
351. Springman E.B., Dikov M.M., and Serafin W.E. Mast cell procarboxypeptidase A. Molecular modeling and biochemical characterization of its processing within secretory granules. J. Biol. Chem. 270 (1995) 1300-1307
352. Stack M.S., and Johnson D.A. Human mast cell tryptase activates single-chain urinary-type plasminogen activator (pro-urokinase). J. Biol. Chem. 269 (1994) 9416-9419
353. Stevens R.L., Qui D., McNeil H.P., Friend D.S., Hunt J.E., Austen K.F., and Zhang J. Transgenic mice that possess a disrupted mast cell protease 5 (mMCP-5) gene cannot store carboxypeptidase A (mMC-CPA) protein in their granules. FASEB J. 10 (1996) 17772
354. Strik M.C., Wolbink A., Wouters D., Bladergroen B.A., Verlaan A.R., van Houdt I.S., Hijlkema S., Hack C.E., and Kummer J.A. Intracellular serpin SERPINB6 (PI6) is abundantly expressed by human mast cells and forms complexes with beta-tryptase monomers. Blood 103 (2004) 2710-2717
355. Sugimoto M., Furuta T., Shirai N., Ikuma M., Sugimura H., and Hishida A. Influences of chymase and angiotensin I-converting enzyme gene polymorphisms on gastric cancer risks in Japan. Cancer Epidemiol. Biomarkers Prev. 15 (2006) 1929-1934
356. Sutton J.C., Bolton S.A., Hartl K.S., Huang M.H., Jacobs G., Meng W., Ogletree M.L., Pi Z., Schumacher W.A., Seiler S.M., Slusarchyk W.A., Treuner U., et al. Synthesis and SAR of 4-carboxy-2-azetidinone mechanism-based tryptase inhibitors. Bioorg. Med. Chem. Lett. 12 (2002) 3229-3233
357. Sylvin H., Dahlback M., Van Der Ploeg I., and Alving K. The tryptase inhibitor APC-366 reduces the acute airway response to allergen in pigs sensitized to Ascaris suum. Clin. Exp. Allergy 32 (2002) 967-971
358. Taipale J., Lohi J., Saarinen J., Kovanen P.T., and Keski-Oja J. Human mast cell chymase and leukocyte elastase release latent transforming growth factor-beta 1 from the extracellular matrix of cultured human epithelial and endothelial cells. J. Biol. Chem. 270 (1995) 4689-4696
359. Takai S., Shiota N., Jin D., and Miyazaki M. Chymase processes big-endothelin-2 to endothelin-2-(1-31) that induces contractile responses in the isolated monkey trachea. Eur. J. Pharmacol. 358 (1998) 229-233
360. Takai S., Jin D., Nishimoto M., Yuda A., Sakaguchi M., Kamoshita K., Ishida K., Sukenaga Y., Sasaki S., and Miyazaki M. Oral administration of a specific chymase inhibitor, NK3201, inhibits vascular proliferation in grafted vein. Life Sci. 69 (2001) 1725-1732
361. Takai S., Jin D., Sakaguchi M., Kirimura K., and Miyazaki M. An orally active chymase inhibitor, BCEAB, suppresses heart chymase activity in the hamster. Jpn. J. Pharmacol. 86 (2001) 124-126
362. Takai S., Jin D., Sakaguchi M., Katayama S., Muramatsu M., Matsumura E., Kim S., and Miyazaki M. A novel chymase inhibitor, 4-[1-([bis-(4-methyl-phenyl)-methyl]-carbamoyl)3-(2-ethoxy-benzyl)-4-oxo-a zetidine-2-yloxy]-benzoic acid (BCEAB), suppressed cardiac fibrosis in cardiomyopathic hamsters. J. Pharmacol. Exp. Ther. 305 (2003) 17-23
363. Takai S., Sakonjo H., Fukuda K., Jin D., Sakaguchi M., Kamoshita K., Ishida K., Sukenaga Y., and Miyazaki M. A novel chymase inhibitor, 2-(5-formylamino-6-oxo-2-phenyl-1,6-dihydropyrimidine-1-yl)-N-[[4-dioxo-1 -phenyl-7-(2-pyridyloxy)]2-heptyl]acetamide (NK3201), suppressed intimal hyperplasia after balloon injury. J. Pharmacol. Exp. Ther. 304 (2003) 841-844
364. Takai S., Jin D., Muramatsu M., Okamoto Y., and Miyazaki M. Therapeutic applications of chymase inhibitors in cardiovascular diseases and fibrosis. Eur. J. Pharmacol. 501 (2004) 1-8
365. Takai S., Jin D., Sakaguchi M., and Miyazaki M. A single treatment with a specific chymase inhibitor, TY-51184, prevents vascular proliferation in canine grafted veins. J. Pharmacol. Sci. 94 (2004) 443-448
366. Tam E.K., and Caughey G.H. Degradation of airway neuropeptides by human lung tryptase. Am. J. Respir. Cell Mol. Biol. 3 (1990) 27-32
367. Tanaka K., Sugiura H., Uehara M., Sato H., Hashimoto-Tamaoki T., and Furuyama J. Association between mast cell chymase genotype and atopic eczema: Comparison between patients with atopic eczema alone and those with atopic eczema and atopic respiratory disease. Clin. Exp. Allergy 29 (1999) 800-803
368. Tani K., Ogushi F., Kido H., Kawano T., Kunori Y., Kamimura T., Cui P., and Sone S. Chymase is a potent chemoattractant for human monocytes and neutrophils. J. Leukoc. Biol. 67 (2000) 585-589
369. Tchougounova E., and Pejler G. Regulation of extravascular coagulation and fibrinolysis by heparin-dependent mast cell chymase. FASEB J. 15 (2001) 2763-2765
370. Tchougounova E., Forsberg E., Angelborg G., Kjellen L., and Pejler G. Altered processing of fibronectin in mice lacking heparin. a role for heparin-dependent mast cell chymase in fibronectin degradation. J. Biol. Chem. 276 (2001) 3772-3777
371. Tchougounova E., Pejler G., and Åbrink M. The chymase, mouse mast cell protease 4, constitutes the major chymotrypsin-like activity in peritoneum and ear tissue. A role for mouse mast cell protease 4 in thrombin regulation and fibronectin turnover. J. Exp. Med. 198 (2003) 423-431
372. Tchougounova E., Lundequist A., Fajardo I., Winberg J.O., Åbrink M., and Pejler G. A key role for mast cell chymase in the activation of pro-matrix metalloprotease-9 and pro-matrix metalloprotease-2. J. Biol. Chem. 280 (2005) 9291-9296
373. Temkin V., Kantor B., Weg V., Hartman M.L., and Levi-Schaffer F. Tryptase activates the mitogen-activated protein kinase/activator protein-1 pathway in human peripheral blood eosinophils, causing cytokine production and release. J. Immunol. 169 (2002) 2662-2669
374. Terakawa M., Tomimori Y., Goto M., Hayashi Y., Oikawa S., and Fukuda Y. Eosinophil migration induced by mast cell chymase is mediated by extracellular signal-regulated kinase pathway. Biochem. Biophys. Res. Commun. 332 (2005) 969-975
375. Terakawa M., Tomimori Y., Goto M., and Fukuda Y. Mast cell chymase induces expression of chemokines for neutrophils in eosinophilic EoL-1 cells and mouse peritonitis eosinophils. Eur. J. Pharmacol. 538 (2006) 175-181
376. Tetlow L.C., and Woolley D.E. Distribution, activation and tryptase/chymase phenotype of mast cells in the rheumatoid lesion. Ann. Rheum. Dis. 54 (1995) 549-555
377. Tomimori Y., Muto T., Fukami H., Saito K., Horikawa C., Tsuruoka N., Saito M., Sugiura N., Yamashiro K., Sumida M., Kakutani S., and Fukuda Y. Chymase participates in chronic dermatitis by inducing eosinophil infiltration. Lab. Invest. 82 (2002) 789-794
378. Tomimori Y., Tsuruoka N., Fukami H., Saito K., Horikawa C., Saito M., Muto T., Sugiura N., Yamashiro K., Sumida M., Kakutani S., and Fukuda Y. Role of mast cell chymase in allergen-induced biphasic skin reaction. Biochem. Pharmacol. 64 (2002) 1187
379. Tomimori Y., Muto T., Saito K., Tanaka T., Maruoka H., Sumida M., Fukami H., and Fukuda Y. Involvement of mast cell chymase in bleomycin-induced pulmonary fibrosis in mice. Eur. J. Pharmacol. 478 (2003) 179-185
380. Toomes C., James J., Wood A.J., Wu C.L., McCormick D., Lench N., Hewitt C., Moynihan L., Roberts E., Woods C.G., Markham A., Wong M., et al. Loss-of-function mutations in the cathepsin C gene result in periodontal disease and palmoplantar keratosis. Nat. Genet. 23 (1999) 421-424
381. Tremaine W.J., Brzezinski A., Katz J.A., Wolf D.C., Fleming T.J., Mordenti J., Strenkoski-Nix L.C., and Kurth M.C. Treatment of mildly to moderately active ulcerative colitis with a tryptase inhibitor (APC 2059): An open-label pilot study. Aliment. Pharmacol. Ther. 16 (2002) 407-413
382. Trong H.L., Newlands G.F., Miller H.R., Charbonneau H., Neurath H., and Woodbury R.G. Amino acid sequence of a mouse mucosal mast cell protease. Biochemistry 28 (1989) 391-395
383. Tsunemi K., Takai S., Nishimoto M., Yuda A., Hasegawa S., Sawada Y., Fukumoto H., Sasaki S., and Miyazaki M. Possible roles of angiotensin II-forming enzymes, angiotensin converting enzyme and chymase-like enzyme, in the human aneurysmal aorta. Hypertens. Res. 25 (2002) 817-822
384. Tsunemi K., Takai S., Nishimoto M., Jin D., Sakaguchi M., Muramatsu M., Yuda A., Sasaki S., and Miyazaki M. A specific chymase inhibitor, 2-(5-formylamino-6- oxo-2-phenyl-1,6-dihydropyrimidine-1-yl)-N-[[3,4-dioxo- 1-phenyl-7-(2-pyridyloxy)]-2-heptyl]acetamide (NK3201), suppresses development of abdominal aortic aneurysm in hamsters. J. Pharmacol. Exp. Ther. 309 (2004) 879-883
385. Uehara Y., Urata H., Ideishi M., Arakawa K., and Saku K. Chymase inhibition suppresses high-cholesterol diet-induced lipid accumulation in the hamster aorta. Cardiovasc. Res. 55 (2002) 870-876
386. Ui H., Andoh T., Lee J.B., Nojima H., and Kuraishi Y. Potent pruritogenic action of tryptase mediated by PAR-2 receptor and its involvement in anti-pruritic effect of nafamostat mesilate in mice. Eur. J. Pharmacol. 530 (2006) 172-178
387. Ulrich P.N., and Boon J.K. The histological localization of heparin in the northern quahog clam, Mercenaria mercenaria. J. Invertebr. Pathol. 78 (2001) 155-159
388. Urata H., Kinoshita A., Misono K.S., Bumpus F.M., and Husain A. Identification of a highly specific chymase as the major angiotensin II-forming enzyme in the human heart [published erratum appears in J. Biol. Chem. (1991 Jun 25) 266(18), 12114]. J. Biol. Chem. 265 (1990) 22348-22357
389. Urata H., Kinoshita A., Perez D.M., Misono K.S., Bumpus F.M., Graham R.M., and Husain A. Cloning of the gene and cDNA for human heart chymase. J. Biol. Chem. 266 (1991) 17173-17179
390. Uratani Y., Takiguchi-Hayashi K., Miyasaka N., Sato M., Jin M., and Arimatsu Y. Latexin, a carboxypeptidase A inhibitor, is expressed in rat peritoneal mast cells and is associated with granular structures distinct from secretory granules and lysosomes. Biochem. J. 346 Pt. 3 (2000) 817-826
391. Vanderslice P., Craik C.S., Nadel J.A., and Caughey G.H. Molecular cloning of dog mast cell tryptase and a related protease: Structural evidence of a unique mode of serine protease activation. Biochemistry 28 (1989) 4148-4155
392. Vanderslice P., Ballinger S.M., Tam E.K., Goldstein S.M., Craik C.S., and Caughey G.H. Human mast cell tryptase: Multiple cDNAs and genes reveal a multigene serine protease family. Proc. Natl. Acad. Sci. USA 87 (1990) 3811-3815
393. Vartio T., Seppa H., and Vaheri A. Susceptibility of soluble and matrix fibronectins to degradation by tissue proteinases, mast cell chymase and cathepsin G. J. Biol. Chem. 256 (1981) 471-477
394. Vliagoftis H., Lacy P., Luy B., Adamko D., Hollenberg M., Befus D., and Moqbel R. Mast cell tryptase activates peripheral blood eosinophils to release granule-associated enzymes. Int. Arch. Allergy Immunol. 135 (2004) 196-204
395. von Heijne G. How signal sequences maintain cleavage specificity. J. Mol. Biol. 173 (1984) 243-251
396. Walter M., Plotnick M., and Schechter N.M. Inhibition of human mast cell chymase by secretory leukocyte proteinase inhibitor: Enhancement of the interaction by heparin. Arch. Biochem. Biophys. 327 (1996) 81-88
397. Walter M., Sutton R.M., and Schechter N.M. Highly Efficient Inhibition of Human Chymase by alpha(2)-Macroglobulin. Arch. Biochem. Biophys. 368 (1999) 276-284
398. Wang H.W., McNeil H.P., Husain A., Liu K., Tedla N., Thomas P.S., Raftery M., King G.C., Cai Z.Y., and Hunt J.E. Delta tryptase is expressed in multiple human tissues, and a recombinant form has proteolytic activity. J. Immunol. 169 (2002) 5145-5152
399. Wang Y., Shiota N., Leskinen M.J., Lindstedt K.A., and Kovanen P.T. Mast cell chymase inhibits smooth muscle cell growth and collagen expression in vitro: Transforming growth factor-beta1-dependent and -independent effects. Arterioscler. Thromb. Vasc. Biol. 21 (2001) 1928-1933
400. Wastling J.M., Scudamore C.L., Thornton E.M., Newlands G.F., and Miller H.R. Constitutive expression of mouse mast cell protease-1 in normal BALB/c mice and its up-regulation during intestinal nematode infection. Immunology 90 (1997) 308-313
401. Wastling J.M., Knight P., Ure J., Wright S., Thornton E.M., Scudamore C.L., Mason J., Smith A., and Miller H.R. Histochemical and ultrastructural modification of mucosal mast cell granules in parasitized mice lacking the beta-chymase, mouse mast cell protease-1. Am. J. Pathol. 153 (1998) 491-504
402. Watanabe N., Miura K., and Fukuda Y. Chymase inhibitor ameliorates eosinophilia in mice infected with Nippostrongylus brasiliensis. Int. Arch. Allergy Immunol. 128 (2002) 235-239
403. Watanabe N., Tomimori Y., Saito K., Miura K., Wada A., Tsudzuki M., and Fukuda Y. Chymase inhibitor improves dermatitis in NC/Nga mice. Int. Arch. Allergy Immunol. 128 (2002) 229-234
404. Wei C.C., Tian B., Perry G., Meng Q.C., Chen Y.F., Oparil S., and Dell'Italia L.J. Differential ANG II generation in plasma and tissue of mice with decreased expression of the ACE gene. Am. J. Physiol. Heart Circ. Physiol. 282 (2002) H2254-H2258
405. Weidinger S., Mayerhofer A., Kunz L., Albrecht M., Sbornik M., Wunn E., Hollweck R., Ring J., and Kohn F.M. Tryptase inhibits motility of human spermatozoa mainly by activation of the mitogen-activated protein kinase pathway. Hum. Reprod. 20 (2005) 456-461
406. Weidinger S., Rummler L., Klopp N., Wagenpfeil S., Baurecht H.J., Fischer G., Holle R., Gauger A., Schafer T., Jakob T., Ollert M., Behrendt H., et al. Association study of mast cell chymase polymorphisms with atopy. Allergy 60 (2005) 1256-1261
407. Wernersson S., Reimer J.M., Poorafshar M., Karlson U., Wermenstam N., Bengten E., Wilson M., Pilstrom L., and Hellman L. Granzyme-like sequences in bony fish shed light on the emergence of hematopoietic serine proteases during vertebrate evolution. Dev. Comp. Immunol. 30 (2006) 901-918
408. Whitaker-Menezes D., Schechter N.M., and Murphy G.F. Serine proteinases are regionally segregated within mast cell granules. Lab. Invest. 72 (1995) 34-41
409. Wolny A., Clozel J.P., Rein J., Mory P., Vogt P., Turino M., Kiowski W., and Fischli W. Functional and biochemical analysis of angiotensin II-forming pathways in the human heart. Circ. Res. 80 (1997) 219-227
410. Wolters P.J., Laig-Webster M., and Caughey G.H. Dipeptidyl peptidase I cleaves matrix-associated proteins and is expressed mainly by mast cells in normal dog airways. Am. J. Respir. Cell Mol. Biol. 22 (2000) 183-190
411. Wolters P.J., Pham C.T., Muilenburg D.J., Ley T.J., and Caughey G.H. Dipeptidyl peptidase I is essential for activation of mast cell chymases, but not tryptases, in mice. J. Biol. Chem. 276 (2001) 18551-18556
412. Wong G.W., Tang Y., Feyfant E., Sali A., Li L., Li Y., Huang C., Friend D.S., Krilis S.A., and Stevens R.L. Identification of a new member of the tryptase family of mouse and human mast cell proteases which possesses a novel COOH-terminal hydrophobic extension. J. Biol. Chem. 274 (1999) 30784-30793
413. Wong G.W., Foster P.S., Yasuda S., Qi J.C., Mahalingam S., Mellor E.A., Katsoulotos G., Li L., Boyce J.A., Krilis S.A., and Stevens R.L. Biochemical and functional characterization of human transmembrane tryptase (TMT)/tryptase gamma. TMT is an exocytosed mast cell protease that induces airway hyperresponsiveness in vivo via an interleukin-13/interleukin-4 receptor alpha/signal transducer and activator of transcription (STAT) 6-dependent pathway. J. Biol. Chem. 277 (2002) 41906-41915
414. Wong G.W., Yasuda S., Morokawa N., Li L., and Stevens R.L. Mouse chromosome 17A3.3 contains 13 genes that encode functional tryptic-like serine proteases with distinct tissue and cell expression patterns. J. Biol. Chem. 279 (2004) 2438-2452
415. Wright C.D., Havill A.M., Middleton S.C., Kashem M.A., Dripps D.J., Abraham W.M., Thomson D.S., and Burgess L.E. Inhibition of allergen-induced pulmonary responses by the selective tryptase inhibitor 1,5-bis-[4-[(3-carbamimidoyl-benzenesulfonylamino)-methyl]-phenoxy]-pen tane (AMG-126737). Biochem. Pharmacol. 58 (1999) 1989-1996
416. Wypij D.M., Nichols J.S., Novak P.J., Stacy D.L., Berman J., and Wiseman J.S. Role of mast cell chymase in the extracellular processing of big- endothelin-1 to endothelin-1 in the perfused rat lung. Biochem. Pharmacol. 43 (1992) 845-853
417. Xia H.Z., Zweiman B., and Schwartz L.B. Levels of tryptase, chymase, and Fc epsilon RI alpha messenger RNA in human skin are unchanged after IgE-dependent stimulation of cutaneous mast cells in vivo. J. Allergy Clin. Immunol. 99 (1997) 224-226
418. Xia Z., Ghildyal N., Austen K.F., and Stevens R.L. Post-transcriptional regulation of chymase expression in mast cells. A cytokine-dependent mechanism for controlling the expression of granule neutral proteases of hematopoietic cells. J. Biol. Chem. 271 (1996) 8747-8753
419. Yoshii M., Jikuhara A., Mori S., Iwagaki H., Takahashi H.K., Nishibori M., and Tanaka N. Mast cell tryptase stimulates DLD-1 carcinoma through prostaglandin- and MAP kinase-dependent manners. J. Pharmacol. Sci. 98 (2005) 450-458
420. Yoshikawa T., Imada T., Nakakubo H., Nakamura N., and Naito K. Rat mast cell protease-I enhances immunoglobulin E production by mouse B cells stimulated with interleukin-4. Immunology 104 (2001) 333-340
421. Yu M., Tsai M., Tam S.Y., Jones C., Zehnder J., and Galli S.J. Mast cells can promote the development of multiple features of chronic asthma in mice. J. Clin. Invest. 116 (2006) 1633-1641
422. Zhao W., Oskeritzian C.A., Pozez A.L., and Schwartz L.B. Cytokine production by skin-derived mast cells: Endogenous proteases are responsible for degradation of cytokines. J. Immunol. 175 (2005) 2635-2642